1
|
Zhang HL, Shang Y. [The value of point-of-care ultrasound in the diagnosis and management of acute respiratory distress syndrome]. Zhonghua Yi Xue Za Zhi 2024; 104:1225-1229. [PMID: 38637160 DOI: 10.3760/cma.j.cn112137-20230906-00407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/20/2024]
Abstract
Acute respiratory distress syndrome (ARDS) continues to cause significant morbidity and mortality worldwide. However, there are currently no corresponding specific medications. Lung, right heart, and diaphragm protective therapy is the cornerstone of ARDS management. Non-invasive, radiation-free, and transportation-free point-of-care ultrasound enables for real-time dynamic evaluation of the lung, right heart, and diaphragm. It is an essential tool for the diagnosis, monitoring, and clinical decision-making of ARDS patients. However, ultrasound has several limitations, and its clinical application must be carefully evaluated in conjunction with clinical symptoms and other monitoring techniques. Further research is needed to determine whether clinical decision-making based on point-of-care ultrasound examination can improve the prognosis of ARDS patients.
Collapse
Affiliation(s)
- H L Zhang
- Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Y Shang
- Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| |
Collapse
|
2
|
Zhao M, Chen GG, Zhang HL, Li QR, Zhou LY, Li Y, Yang J, Wu JX, Li YL, Huangfu H. [Development and validation of a persistent postural-perceptual dizziness screening questionnaire]. Zhonghua Yi Xue Za Zhi 2024; 104:1143-1148. [PMID: 38583044 DOI: 10.3760/cma.j.cn112137-20231111-01067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/08/2024]
Abstract
Objective: To develop a simple screening questionnaire for persistent postural-perceptual dizziness (PPPD) and evaluate its screening ability. Methods: A convenience sample of 296 individuals who met the inclusion criteria between November 2021 and January 2023 were prospectively selected for three rounds of screening at the Vertigo Specialty Clinic of the Department of Otorhinolaryngology-Head and Neck Surgery in the First Hospital of Shanxi Medical University. In conjunction with expert opinion and statistical analysis, the first and second rounds of screening were used to modify and finalize the questionnaire entries, and the third round of screening was used to evaluate the questionnaire's screening ability. Independent sample t-test was used for inter group comparison, reliability and validity indicators were employed to screen and evaluate questionnaire entries, and the receiver operating characteristic (ROC) curve was plotted to determine the optimal cut-off value and corresponding sensitivity and specificity. Results: The final PPPD screening questionnaire entries included 21 items. In evaluating the reliability of this questionnaire, the Cronbach's alpha coefficient was 0.831, the half folding coefficient was 0.742, the content validity was 0.86, and the Kaiser-Meyer-Olkin (KMO) value in the structural validity was 0.811. Additionally, there were six factors with characteristic root>1 and a cumulative contribution rate of 62.62%. The area under the ROC curve of the screening questionnaire was 0.935 (95%CI: 0.877-0.992), and the optimal cut-off value was 8.5, with a sensitivity of 85.0%, a specificity of 85.5%, and a Kappa value of 0.653. Conclusion: The PPPD simple screening questionnaire designed in this study has a high sensitivity and specificity, making it a useful tool for identifying PPPD patients.
Collapse
Affiliation(s)
- M Zhao
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - G G Chen
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - H L Zhang
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - Q R Li
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - L Y Zhou
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - Y Li
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - J Yang
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - J X Wu
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - Y L Li
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - H Huangfu
- First Clinical Medical College of Shanxi Medical University, Department of Otolaryngology Head and Neck Surgery, First Hospital of Shanxi Medical University, Taiyuan 030001, China
| |
Collapse
|
3
|
Cai SJ, Zhang LL, Chen SY, Zhu TT, Xu M, Zheng YM, Zhang HL. [The diagnostic value of lung ultrasound in children with community-acquired pneumonia]. Zhonghua Er Ke Za Zhi 2024; 62:331-336. [PMID: 38527503 DOI: 10.3760/cma.j.cn112140-20231201-00403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/27/2024]
Abstract
Objective: To investigate the diagnostic value of lung ultrasound in hospitalized children with community-acquired pneumonia (CAP). Methods: In the cross-sectional study, a total of 422 children with CAP who were hospitalized in the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, from February 2021 to August 2022 and completed lung ultrasound examination within 48 hours after admission were enrolled. The clinical characteristics, lung ultrasound and chest CT were collected. The patients were divided into two groups according to the signs of pneumonia indicated by chest CT, and the signs of lung ultrasound with diagnostic value were screened according to the signs of pneumonia indicated by chest CT by least absolute shrinkage and selection operator (Lasso) regression. According to severity of the disease, the children were divided into the severe group and the mild group, and the differences of lung ultrasound signs between the two groups were compared. Kruskal-Wallis test, Fisher's exact test was selected for comparison between groups. Random forest classifier wes used to evaluate the value of lung ultrasound in the diagnosis of CAP and prediction of severe pneumonia in children. The receiver operating characteristic curve was used to evaluate the prediction effect. Use DeLong test to compare the area under the curve. Results: Among the 422 cases of CAP, there were 258 males and 164 females, and the age of onset was 2.8 (1.3, 4.3) years. The confluent B-line, consolidation and pleural effusion detected by lung ultrasound were 309 cases (73.2%), 232 cases (55.0%) and 16 cases (3.8%), respectively, and the size of consolidation was 3.0 (0, 11.0) mm. One hundred and ten children (26.1%) with CAP completed chest CT. There were 90 cases with signs of pneumonia in chest CT and 20 cases without signs of pneumonia. Lasso was used for feature selection.Lung consolidation (OR=2.46), bilateral lung consolidation (OR=1.16) and confluent B-line (OR=1.34) were the main index. With random forest classifier, the accuracy of models using full variables and Lasso-selected variables were 0.79 (95%CI 0.70-0.86) and 0.79 (95%CI 0.70-0.86), the sensitivity were 0.81 and 0.81, and the specificity were 0.75 and 0.70, and the area under curve were 0.87 (95%CI 0.81-0.94, P<0.001) and 0.84 (95%CI 0.76-0.91, P<0.001), respectively. There were 97 cases in severe group and 325 cases in mild group. Compared with the mild group, the detection rate of consolidation, multiple consolidation, the size of consolidation and the size of consolidation was adjusted by body surface area (consolidation size/body surface area) in severe group were higher (66 cases (68.0%) vs. 166 cases (51.1%), 42 cases (43.3%) vs. 93 cases (28.6%), 8.0 (0, 17.0) vs. 1.0 (0, 9.0) mm, 12.5 (0, 24.6) vs. 2.1 (0, 17.6), χ2=8.59, 9.98, Z=14.40, 12.79, all P<0.05). Using lung ultrasound lung consolidation size and consolidation size/body surface area to predict the severe CAP, the optimal cut-off value were 6.7 mm and 10.2, the accuracy was 0.80 (95%CI 0.75-0.83) and 0.89 (95%CI 0.86-0.92), the sensitivity was 0.99 and 0.99, the specificity was 0.14 and 0.56, respectively, and the area under the curve was 0.66 (95%CI 0.60-0.72, P<0.001) and 0.76 (95%CI 0.70-0.83, P<0.001), respectively. The area under the curve of consolidation size/body surface area was higher than that of consolidation size (Z=5.50, P<0.001). Conclusions: Consolidation and confluent B-line, are important index for lung ultrasound diagnosis of CAP in children. The actual consolidation size adjusted by body surface area is superior to the size of consolidation in predicting severe CAP.
Collapse
Affiliation(s)
- S J Cai
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaCai Shujing is working at the Department of Neonatology, Jinhua Maternal and Child Health Care Hospital, Jinhua 321000, China
| | - L L Zhang
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaCai Shujing is working at the Department of Neonatology, Jinhua Maternal and Child Health Care Hospital, Jinhua 321000, China
| | - S Y Chen
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaCai Shujing is working at the Department of Neonatology, Jinhua Maternal and Child Health Care Hospital, Jinhua 321000, China
| | - T T Zhu
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaCai Shujing is working at the Department of Neonatology, Jinhua Maternal and Child Health Care Hospital, Jinhua 321000, China
| | - M Xu
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaCai Shujing is working at the Department of Neonatology, Jinhua Maternal and Child Health Care Hospital, Jinhua 321000, China
| | - Y M Zheng
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaCai Shujing is working at the Department of Neonatology, Jinhua Maternal and Child Health Care Hospital, Jinhua 321000, China
| | - H L Zhang
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, ChinaCai Shujing is working at the Department of Neonatology, Jinhua Maternal and Child Health Care Hospital, Jinhua 321000, China
| |
Collapse
|
4
|
Dong XY, Zou YX, Lyu FF, Yang WH, Zhang HL, Niu YH, Wang HJ, Guo R, Wang X, Li L, Lin ZH, Luo L, Lu DL, Lu Q, Liu HM, Chen LN. [A multicenter study on respiratory pathogen detection with Mycoplasma pneumoniae pneumonia in children]. Zhonghua Er Ke Za Zhi 2024; 62:310-316. [PMID: 38527500 DOI: 10.3760/cma.j.cn112140-20240117-00054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/27/2024]
Abstract
Objective: To analyze the status of respiratory pathogen detection and the clinical features in children with Mycoplasma pneumoniae pneumonia (MPP). Methods: A prospective, multicenter study was conducted to collect clinical data, including medical history, laboratory examinations and multiplex PCR tests of children diagnosed with MPP from 4 hospitals in China between November 15th and December 20th, 2023. The multiplex PCR results and clinical characteristics of MPP children in different regions were analyzed. The children were divided into severe and mild groups according to the severity of the disease. Patients in the severe group were further divided into Mycoplasma pneumoniae (MP) alone and Multi-pathogen co-detection groups based on whether other pathogens were detected besides MP, to analyze the influence of respiratory pathogen co-detection rate on the severity of the disease. Mann-Whitney rank sum test and Chi-square test were used to compare data between independent groups. Results: A total of 298 children, 136 males and 162 females, were enrolled in this study, including 204 children in the severe group with an onset age of 7.0 (6.0, 8.0) years, and 94 children in the mild group with an onset age of 6.5 (4.0, 7.8) years. The level of C-reactive protein, D-dimer, lactic dehydrogenase (LDH) were significantly higher (10.0 (5.0, 18.0) vs. 5.0 (5.0, 7.5) mg/L, 0.6 (0.4, 1.1) vs. 0.5 (0.3, 0.6) mg/L, 337 (286, 431) vs. 314 (271, 393) U/L, Z=2.02, 2.50, 3.05, all P<0.05), and the length of hospitalization was significantly longer in the severe group compared with those in mild group (6.0 (6.0, 7.0) vs. 5.0 (4.0, 6.0) d, Z=4.37, P<0.05). The time from onset to admission in severe MPP children was significantly shorter than that in mild MPP children (6.0 (5.0, 9.5) vs. 9.0 (7.0, 13.0) d, Z=2.23, P=0.026). All patients completed the multiplex PCR test, with 142 cases (47.7%) MPP children detected with 21 pathogens including adenovirus 25 cases (8.4%), human coronavirus 23 cases (7.7%), rhinovirus 21 cases (7.0%), Streptococcus pneumoniae 21 cases (7.0%), influenza A virus 18 cases (6.0%). The pathogens with the highest detection rates in Tianjin, Shanghai, Wenzhou and Chengdu were Staphylococcus aureus at 10.7% (8/75), adenovirus at 13.0% (10/77), adenovirus at 15.3% (9/59), and both rhinovirus and Haemophilus influenzae at 11.5% (10/87) each. The multi-pathogen co-detection rate in severe MPP children was significantly higher than that in mild MPP group (52.9% (108/204) vs. 36.2% (34/94), χ²=10.62,P=0.005). Among severe MPP children, there are 89 cases in the multi-pathogen co-detection group and 73 cases in the simple MPP group. The levels of LDH, D-dimer and neutrophil counts in the multi-pathogen co-detection group were significantly higher than those in the simple MPP group (348 (284, 422) vs. 307 (270, 358) U/L, 0.8 (0.5, 1.5) vs. 0.6 (0.4, 1.0) mg/L, 4.99 (3.66, 6.89)×109 vs. 4.06 (2.91, 5.65)×109/L, Z=5.17, 4.99, 6.11, all P<0.05). Conclusions: The co-detection rate of respiratory pathogens, LDH and D-dimer in children with severe MPP were higher than those with mild MPP. Among severe MPP children the stress response of children in co-detection group was more serious than that of children with simple MPP.
Collapse
Affiliation(s)
- X Y Dong
- Department of Pulmonology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - Y X Zou
- Department of Pulmonology, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Machang District, Tianjin 300074, China
| | - F F Lyu
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - W H Yang
- Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - H L Zhang
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Y H Niu
- Department of Pulmonology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - H J Wang
- Department of Pulmonology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - R Guo
- Department of Pulmonology, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Machang District, Tianjin 300074, China
| | - X Wang
- Department of Pulmonology, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Machang District, Tianjin 300074, China
| | - L Li
- Department of Pulmonology, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Machang District, Tianjin 300074, China
| | - Z H Lin
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - L Luo
- Department of Pediatric Pulmonology, Yaan People's Hospital, Yaan 625000, China
| | - D L Lu
- Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - Q Lu
- Department of Pulmonology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - H M Liu
- Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - L N Chen
- Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| |
Collapse
|
5
|
Zheng YM, Zhang HL. [Diagnosis and treatment of radiation pneumonia in children]. Zhonghua Er Ke Za Zhi 2024; 62:389-391. [PMID: 38527515 DOI: 10.3760/cma.j.cn112140-20231221-00449] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/27/2024]
Affiliation(s)
- Y M Zheng
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - H L Zhang
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| |
Collapse
|
6
|
Ding CZ, Wang GL, Jiang GQ, Wang HT, Liu YY, Zhang HL, Sun F, Wei L. [circDDX17 targets miR-223-3p / RIP3 to regulate the proliferation and apoptosis of non-small cell lung cancer cells]. Zhonghua Zhong Liu Za Zhi 2024; 46:239-248. [PMID: 38494770 DOI: 10.3760/cma.j.cn112152-20231024-00243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/19/2024]
Abstract
Objective: To explore the molecular mechanism of circDDX17 regulating the proliferation and apoptosis of non-small cell lung cancer cells by targeting the miR-223-3p/RIP3 molecular axis. Methods: The expression levels of circDDX17, miR-223-3p, and RIP3 in human normal lung epithelial cell lines BEAS-2B and non-small cell lung cancer cells H1299, A549, and H446 were detected by reverse transcription-quantitative real-time polymerase chain reaction (RT-qPCR). The plasmids of pcDNA, pcDNA-circDDX17, anti-miR-con, anti-miR-223-3p, pcDNA-circDDX17 and miR-con, pcDNA-circDDX17 and miR-223-3p mimics were transfected into H1299 cells. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H tetrazolium bromide (MTT) assay was used to detect the cell proliferation. Flow cytometry was used to detect the cell cycle and cell apoptosis. Plate cloning experiment was used to detect cell proliferation ability. The dual luciferase report experiment was applied to verify the targeting relationship between miR-223-3p with circDDX17 and RIP3. Western blot was used to detect the protein expression of cyclinD1, CDK2, cleaved caspase-3 and Bax. Results: The expression levels of circDDX17 and RIP3 mRNA in H1299, A549, and H446 cells were significantly reduced (P<0.05), the expression level of miR-223-3p mRNA was significantly increased (P<0.05) compared with BEAS-2B. The cell viability [(69.46±4.68)%], the number of cell clones (83.49±7.86), the proportion of cells in S phase [(22.52±1.41) %], the protein expression levels of cyclinD1 and CDK2 in PCDNa-CircDDX17 group were lower than those in pcDNA group [(97.54±7.72)%, 205.03±13.37, (28.69±1.49)%, respectively, P<0.05], while the percentage of G0/G1 phase cells [(64.45±3.56)%], apoptosis rate [(18.36±1.63)%], the protein expression levels of cleaved caspase-3 and Bax in pcDNA-circDDX17 group were higher than those of pcDNA group [(51.33±2.76) % and (5.21±0.54) %, respectively, P<0.05]. The viability [(72.64±5.44)%], the number of cell clones (78.16±8.23), the proportion of S-stage cells [(21.34±1.59) %], the protein expression levels of CyclinD1 and CDK2 in anti-miR-223-3p group were lower than those in anti-miR-con group [(103.47±6.25)%, 169.32±14.53, (28.43±1.26)%, respectively, P<0.05]. Percentage of G0/G1 phase cells [(62.86±3.28)%], apoptosis rate [(14.64±1.67)%], the protein expression levels of cleaved caspase-3 and Bax in the anti-miR-223-3p group were higher than those of anti-miR-con group [(51.33±2.71)% and (4.83±0.39)%, respectively, P<0.05]. MiR-223-3p has complementary sites with circDDX17 or RIP3. The viability [(135.45±9.28)%], the number of cell clones (174.64±10.68), the proportion of S-phase cells [(26.39±2.25)%], the protein expression levels of cyclinD1 and CDK2 in pcDNA-circDDX17+miR-223-3p group were higher than those in pcDNA-circDDX17+miR-con group [(101.56±6.68)%, 107.65±7.62, (21.64±1.72)%, P<0.05]. Percentage of G0/G1 phase cells [(56.64±2.76)%], apoptosis rate [(8.34±0.76)%], the protein expression levels of cleaved caspase-3 and Bax in pcDNA-circDDX17+miR-223-3p group were lower than those of pcDNA-circDDX17+miR-con group [(64.03±3.48)% and (15.21±1.18)%, respectively, P<0.05]. Conclusion: circDDX17 could inhibit the proliferation and induce apoptosis of non-small cell lung cancer cells via targeting the miR-223-3p / RIP3 molecular axis.
Collapse
Affiliation(s)
- C Z Ding
- Department of Thoracic Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China
| | - G L Wang
- Department of Thoracic Surgery, Henan Chest Hospital, Zhengzhou 450008, China
| | - G Q Jiang
- Department of Thoracic Surgery, Henan Chest Hospital, Zhengzhou 450008, China
| | - H T Wang
- Department of Thoracic Surgery, Henan Chest Hospital, Zhengzhou 450008, China
| | - Y Y Liu
- Department of Thoracic Surgery, Henan Chest Hospital, Zhengzhou 450008, China
| | - H L Zhang
- Department of Thoracic Surgery, Henan Chest Hospital, Zhengzhou 450008, China
| | - F Sun
- Department of Respiratory, Henan Chest Hospital, Zhengzhou 450008, China
| | - L Wei
- Department of Thoracic Surgery, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou 450003, China
| |
Collapse
|
7
|
Zhao SY, Liu HM, Lu Q, Liu XC, Hong JG, Liu EM, Zou YX, Yang M, Chen ZM, Zhang HL, Zhao DY, Zhang XB, Yin Y, Dong XY, Lu XX, Liu JR, Chen LN. [Interpretation of key points in diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (November 2023)]. Zhonghua Er Ke Za Zhi 2024; 62:108-113. [PMID: 38228509 DOI: 10.3760/cma.j.cn112140-20231120-00382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/18/2024]
Affiliation(s)
- S Y Zhao
- Department of No.2 Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing 100045, China
| | - H M Liu
- Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - Q Lu
- Department of Pulmonology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - X C Liu
- Department of No.2 Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing 100045, China
| | - J G Hong
- Department of Pediatrics, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200080, China
| | - E M Liu
- Department of Respiratory, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - Y X Zou
- Department of Pulmonology, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Machang Compus, Tianjin 300074, China
| | - M Yang
- Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China
| | - Z M Chen
- Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China
| | - H L Zhang
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - D Y Zhao
- Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| | - X B Zhang
- Department of Respiratory Disease, Children's Hospital of Fudan University, Shanghai 201102, China
| | - Y Yin
- Department of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - X Y Dong
- Department of Pulmonology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - X X Lu
- Department of Respiratory Medicine, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430015, China
| | - J R Liu
- Department of No.2 Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing 100045, China
| | - L N Chen
- Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| |
Collapse
|
8
|
Wang JT, Li L, Niu M, Zhu QL, Zhao ZW, Kotani K, Yamamoto A, Zhang HJ, Li SX, Xu D, Kang N, Li XG, Zhang KP, Sun J, Wu FZ, Zhang HL, Liu DX, Lyu MH, Ji JS, Kawada N, Xu K, Qi XL. [HVPG minimally invasive era: exploration based on forearm venous approach]. Zhonghua Gan Zang Bing Za Zhi 2024; 32:35-39. [PMID: 38320789 DOI: 10.3760/cma.j.cn501113-20231220-00289] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/15/2024]
Abstract
Objective: The transjugular or transfemoral approach is used as a common method for hepatic venous pressure gradient (HVPG) measurement in current practice. This study aims to confirm the safety and effectiveness of measuring HVPG via the forearm venous approach. Methods: Prospective recruitment was conducted for patients with cirrhosis who underwent HVPG measurement via the forearm venous approach at six hospitals in China and Japan from September 2020 to December 2020. Patients' clinical baseline information and HVPG measurement data were collected. The right median cubital vein or basilic vein approach for all enrolled patients was selected. The HVPG standard process was used to measure pressure. Research data were analyzed using SPSS 22.0 statistical software. Quantitative data were used to represent medians (interquartile ranges), while qualitative data were used to represent frequency and rates. The correlation between two sets of data was analyzed using Pearson correlation analysis. Results: A total of 43 cases were enrolled in this study. Of these, 41 (95.3%) successfully underwent HVPG measurement via the forearm venous approach. None of the patients had any serious complications. The median operation time for HVPG detection via forearm vein was 18.0 minutes (12.3~38.8 minutes). This study confirmed that HVPG was positively closely related to Child-Pugh score (r = 0.47, P = 0.002), albumin-bilirubin score (r = 0.37, P = 0.001), Lok index (r = 0.36, P = 0.02), liver stiffness (r = 0.58, P = 0.01), and spleen stiffness (r = 0.77, P = 0.01), while negatively correlated with albumin (r = -0.42, P = 0.006). Conclusion: The results of this multi-centre retrospective study suggest that HVPG measurement via the forearm venous approach is safe and feasible.
Collapse
Affiliation(s)
- J T Wang
- Hebei Province Key Laboratory of Hepatocirrhosis and Portal Hypertension, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai 054000, China
| | - L Li
- Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China
| | - M Niu
- Interventional Department, the First Affiliated Hospital of China Medical University, Shenyang 110000, China
| | - Q L Zhu
- Department of Gastroenterology, Affiliated Hospital of Southwest Medical University, Lanzhou 646000, China
| | - Z W Zhao
- Interventional Diagnosis and Treatment Center, Lishui Central Hospital,Lishui 323000, China
| | - K Kotani
- Department of Hepatology, Osaka Municipal University Hospital, Osaka City, Japan
| | - A Yamamoto
- Department of Interventional Radiology, Faculty of Medicine, Osaka City University, Osaka City, Japan
| | - H J Zhang
- Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China
| | - S X Li
- Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China
| | - D Xu
- Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China
| | - N Kang
- Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China
| | - X G Li
- Interventional Department, Lanzhou University First Hospital, Lanzhou 730000, China
| | - K P Zhang
- Hebei Province Key Laboratory of Hepatocirrhosis and Portal Hypertension, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai 054000, China
| | - J Sun
- Interventional Department, the First Affiliated Hospital of China Medical University, Shenyang 110000, China
| | - F Z Wu
- Interventional Diagnosis and Treatment Center, Lishui Central Hospital,Lishui 323000, China
| | - H L Zhang
- Interventional Diagnosis and Treatment Center, Lishui Central Hospital,Lishui 323000, China
| | - D X Liu
- Hebei Province Key Laboratory of Hepatocirrhosis and Portal Hypertension, Xingtai People's Hospital Affiliated to Hebei Medical University, Xingtai 054000, China
| | - M H Lyu
- Department of Gastroenterology, Affiliated Hospital of Southwest Medical University, Lanzhou 646000, China
| | - J S Ji
- Interventional Diagnosis and Treatment Center, Lishui Central Hospital,Lishui 323000, China
| | - N Kawada
- Department of Hepatology, Osaka Municipal University Hospital, Osaka City, Japan
| | - K Xu
- Interventional Department, the First Affiliated Hospital of China Medical University, Shenyang 110000, China
| | - X L Qi
- Portal Hypertension Centers, Southeast University Affiliated Zhongda Hospital, Nanjing 210009,China
| |
Collapse
|
9
|
Liu CL, Chen DJ, Chen CY, Zhou XH, Jiang Y, Liu JY, Chen YE, Hu CR, Dong JJ, Li P, Wen M, Li YH, Zhang HL. [Clinical analysis of 86 cases of acute fatty liver of pregnancy]. Zhonghua Fu Chan Ke Za Zhi 2023; 58:896-902. [PMID: 38123195 DOI: 10.3760/cma.j.cn112141-20230814-00047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]
Abstract
Objective: To investigate the clinical characteristics and maternal and fetal prognosis of pregnant women with acute fatty liver of pregnancy (AFLP). Methods: The clinical data of 86 AFLP pregnant women admitted to the Third Affiliated Hospital of Guangzhou Medical University from September 2017 to August 2022 were collected, and their general data, clinical characteristics, laboratory tests and maternal and fetal outcomes were retrospectively analyzed. Results: (1) General information: the age of the 86 pregnant women with AFLP was (30.8±5.4) years, and the body mass index was (21.0±2.5) kg/m2. There were 50 primiparas (58.1%, 50/86) and 36 multiparas (41.9%, 36/86). There were 64 singleton pregnancies (74.4%, 64/86) and 22 twin pregnancies (25.6%, 22/86). (2) Clinical characteristics: the main complaints of AFLP pregnant women were gastrointestinal symptoms, including epigastric pain (68.6%, 59/86), nausea (47.7%, 41/86), anorexia (46.5%, 40/86), vomiting (39.5%, 34/86). The main non-gastrointestinal symptoms were jaundice of skin and/or scleral (54.7%, 47/86), edema (38.4%, 33/86), fatigue (19.8%, 17/86), bleeding tendency (16.3%, 14/86), polydipsia or polyuria (14.0%, 12/86), skin itching (8.1%, 7/86), and 17.4% (15/86) AFLP pregnant women had no obvious symptoms. (3) Laboratory tests: the incidence of liver and kidney dysfunction and abnormal coagulation function in AFLP pregnant women was high, and the levels of blood ammonia, lactate dehydrogenase and lactic acid were increased, and the levels of hemoglobin, platelet and albumin decreased. However, only 24 cases (27.9%, 24/86) of AFLP pregnant women showed fatty liver by imageology examination. (4) Pregnancy outcomes: ① AFLP pregnant women had a high incidence of pregnancy complications, mainly including renal insufficiency (95.3%, 82/86), preterm birth (46.5%, 40/86), hypertensive disorders in pregnancy (30.2%, 26/86), gestational diabetes mellitus (36.0%, 31/86), fetal distress (24.4%, 21/86), pulmonary infection (23.3%, 20/86), disseminated intravascular coagulation (16.3%, 14/86), multiple organ dysfunction syndrome (16.3%, 14/86), hepatic encephalopathy (9.3%, 8/86), and intrauterine fetal death (2.3%, 2/86). ② Treatment and outcome of AFLP pregnant women: the intensive care unit transfer rate of AFLP pregnant women was 66.3% (57/86). 82 cases were improved and discharged after treatment, 2 cases were transferred to other hospitals for follow-up treatment, and 2 cases (2.3%, 2/86) died. ③ Neonatal outcomes: except for 2 cases of intrauterine death, a total of 106 neonates were delivered, including 39 cases (36.8%, 39/106) of neonatal asphyxia, 63 cases (59.4%, 63/106) of neonatal intensive care unit admission, and 3 cases (2.8%, 3/106) of neonatal death. Conclusions: AFLP is a severe obstetric complication, which is harmful to mother and fetus. In the process of clinical diagnosis and treatment, attention should be paid to the clinical manifestations and laboratory tests of pregnant women, early diagnosis and active treatment, so as to improve maternal and fetal outcomes.
Collapse
Affiliation(s)
- C L Liu
- Department of Obstetrics and Gynecology, the Third Affiliated Hospital of Guangzhou Medical University, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangzhou 510150, China
| | - D J Chen
- Department of Obstetrics and Gynecology, the Third Affiliated Hospital of Guangzhou Medical University, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangzhou 510150, China
| | - C Y Chen
- Department of Obstetrics and Gynecology, the Third Clinical College of Guangzhou Medical University, Guangzhou 511436, China
| | - X H Zhou
- Department of Obstetrics and Gynecology, the Third Clinical College of Guangzhou Medical University, Guangzhou 511436, China
| | - Y Jiang
- Department of Obstetrics and Gynecology, the Third Clinical College of Guangzhou Medical University, Guangzhou 511436, China
| | - J Y Liu
- Department of Obstetrics and Gynecology, the Third Clinical College of Guangzhou Medical University, Guangzhou 511436, China
| | - Y E Chen
- Department of Obstetrics and Gynecology, the Third Clinical College of Guangzhou Medical University, Guangzhou 511436, China
| | - C R Hu
- Department of Obstetrics and Gynecology, the Third Clinical College of Guangzhou Medical University, Guangzhou 511436, China
| | - J J Dong
- Department of Obstetrics and Gynecology, the Third Affiliated Hospital of Guangzhou Medical University, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangzhou 510150, China
| | - P Li
- Department of Obstetrics and Gynecology, the Maternal and Child Health Hospital of Hunan Province, Changsha 410028, China
| | - M Wen
- Department of Obstetrics and Gynecology, the Fourth People's Hospital of Guiyang, Guiyang 550007, China
| | - Y H Li
- Department of Obstetrics and Gynecology, the First People's Hospital of Yulin, Yulin 537000, China
| | - H L Zhang
- Department of Obstetrics and Gynecology, the Third Affiliated Hospital of Guangzhou Medical University, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangzhou 510150, China
| |
Collapse
|
10
|
Jin WG, Zhu TT, Zhang HL. [Analysis of respiratory sounds based on electronic stethoscope and its application in pediatric respiratory diseases: current status and future prospects]. Zhonghua Er Ke Za Zhi 2023; 61:949-951. [PMID: 37803868 DOI: 10.3760/cma.j.cn112140-20230209-00089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 10/08/2023]
Affiliation(s)
- W G Jin
- Department of Children's Respiration Disease, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325000, China
| | - T T Zhu
- Department of Children's Respiration Disease, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325000, China
| | - H L Zhang
- Department of Children's Respiration Disease, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325000, China
| |
Collapse
|
11
|
Zhou Q, Zhang HL, Jiang LY, Shi YK, Chen Y, Yu JM, Zhou CC, He Y, Hu YP, Liang ZA, Pan YY, Zhuo WL, Song Y, Wu G, Chen GY, Lu Y, Zhang CY, Zhang YP, Cheng Y, Lu S, Wang CL, Zhou JY, Liu YP, He JX, Wang J, Wu YL. Real-world evidence of osimertinib in Chinese patients with EGFR T790M-positive non-small cell lung cancer: a subgroup analysis from ASTRIS study. J Cancer Res Clin Oncol 2023; 149:10771-10780. [PMID: 37316692 PMCID: PMC10423102 DOI: 10.1007/s00432-023-04923-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Accepted: 05/23/2023] [Indexed: 06/16/2023]
Abstract
PURPOSE ASTRIS study aimed the largest to evaluate the effectiveness and safety of second- or higher-line osimertinib in patients with advanced/metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC) in the real-world setting. Here we report the results of Chinese patients in ASTRIS study. METHODS Adults with EGFR T790M-positive advanced NSCLC pretreated with EGFR-tyrosine kinase inhibitor (EGFR-TKI), having a WHO performance status score of 0-2 and asymptomatic, stable central nervous system (CNS) metastases were included. All patients received once-daily osimertinib 80 mg orally. The outcomes included investigator-assessed clinical response, progression-free survival (PFS), time-to-treatment discontinuation (TTD), and safety. RESULTS A total of 1350 patients were included. Response rate was 55.7% (95% confidence interval [CI] 0.53-0.58). The median PFS and the median TTD were 11.7 months (95% CI 11.1-12.5) and 13.9 months (95% CI 13.1-15.2), respectively. Overall, 389 patients (28.8%) had at least one protocol-specified adverse event (AE); AEs of interstitial lung diseases/pneumonitis-like events and QT prolongation were reported in 3 (0.2%) and 59 (4.4%) patients, respectively. CONCLUSION Osimertinib was effective in Chinese patients with T790M-positive NSCLC who had progressed after first- or second-generation EGFR-TKI in real-word setting and the results were consistent with ASTRIS study overall population and AURA studies. No new safety signals or events were identified. CLINICAL TRIAL NUMBER NCT02474355.
Collapse
Affiliation(s)
- Qing Zhou
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
| | - He-Long Zhang
- Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China
| | - Li-Yan Jiang
- Department of Respiratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
| | - Yuan-Kai Shi
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Yuan Chen
- Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Jin-Ming Yu
- Department of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China
| | - Cai-Cun Zhou
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China
| | - Yong He
- Department of Respiratory Medicine, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Chongqing, China
| | - Yan-Ping Hu
- Department of Oncology, Hubei Cancer Hospital, Wuhan, China
| | - Zong-An Liang
- Department of Respiratory and Critical Care Medicine, West China School of Medicine and West China Hospital, Sichuan University, Sichuan, China
| | - Yue-Yin Pan
- Department of Oncology, Anhui Medical University, Hefei, China
| | - Wen-Lei Zhuo
- Department of Oncology, Xinqiao Hospital, The Third Military Medical University, Chongqing, China
| | - Yong Song
- Department of Respiration, General Hospital of Eastern Theater Command of Chinese People's Liberation Army, Nanjing, China
| | - Gang Wu
- Cancer Center, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China
| | - Gong-Yan Chen
- Department of Respiration, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China
| | - You Lu
- Department of Thoracic Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China
| | - Cui-Ying Zhang
- Cancer Center, Inner Mongolia Autonomous Region People's Hospital, Huhhot, China
| | - Yi-Ping Zhang
- Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China
| | - Ying Cheng
- Department of Oncology, Jilin Cancer Hospital, Changchun, China
| | - Shun Lu
- Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China
| | - Chang-Li Wang
- Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
| | - Jian-Ying Zhou
- Department of Respiratory Disease, Thoracic Disease Center, First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China
| | - Yun-Peng Liu
- Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China
| | - Jian-Xing He
- Department of Thoracic Surgery, Guangzhou Institute for Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
| | - Jie Wang
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Yi-Long Wu
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
| |
Collapse
|
12
|
Zhao M, Chen GG, Zhang HL, Wu JX, Yang J, Li Y, Zhou LY. [Progresses of serum estrogen in predicting the progression of common paroxysmal vertigo disease in women]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2023; 58:808-811. [PMID: 37599246 DOI: 10.3760/cma.j.cn115330-20221116-00690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 08/22/2023]
Affiliation(s)
- M Zhao
- The First Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China
| | - G G Chen
- Department of Otolaryngology, Head and Neck Surgery, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - H L Zhang
- Department of Otolaryngology, Head and Neck Surgery, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - J X Wu
- Department of Otolaryngology, Head and Neck Surgery, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - J Yang
- Department of Otolaryngology, Head and Neck Surgery, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - Y Li
- Department of Otolaryngology, Head and Neck Surgery, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - L Y Zhou
- Department of Otolaryngology, Head and Neck Surgery, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
| |
Collapse
|
13
|
Wang XZ, Zhang HL, Xi YF. [Progress on the role of interleukin family in colorectal cancer]. Zhonghua Bing Li Xue Za Zhi 2023; 52:531-534. [PMID: 37106304 DOI: 10.3760/cma.j.cn112151-20220928-00819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Affiliation(s)
- X Z Wang
- The Second Clinical Medical College, Shanxi Medical University, Taiyuan 030001, China
| | - H L Zhang
- Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China
| | - Y F Xi
- Department of Pathology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China
| |
Collapse
|
14
|
Zhang HL, Xiang YK, Hu H, Zhang C, Kong XY, Tian FZ, Da XB, Qiu C, Lyu BN, Wang YB, Yang YL. [Diagnostic value of lipoprotein-associated phospholipase A2 in OPBR combined with gallbladder cholesterol deposition]. Zhonghua Yi Xue Za Zhi 2023; 103:1225-1229. [PMID: 37087406 DOI: 10.3760/cma.j.cn112137-20220831-01844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
Abstract
Objective: To study the diagnostic value of lipoprotein-associated phospholipase A2(LP-PL-A2) in occult pancreaticobiliary reflux(OPBR) combined with gallbladder cholesterol deposition. Methods: This was a case-control study. Forty-six patients with OPBR who underwent gallbladder surgery at Shanghai East Hospital from December 2020 to October 2021, with gallbladder cholesterol deposition as the case group and the remainder as the control group, were included for analysis of their clinical data. Results: There were 21 cases in the case group, with 10 males and 11 females, and aged (57±12) years; 25 cases in the control group, with 11 males and 14 females, and aged (56±10) years. Serum LP-PL-A2 [(551.62±128.69) U/L] was significantly higher in the case group than in the control group [(436.70±135.88) U/L] (t=-2.80,P<0.01).Univariate analysis showed that LP-PL-A2 was a risk factor for OPBR combined with gallbladder cholesterol deposition, OR(95%CI):1.007(1.002-1.012), P=0.011. The area under the receiver operating characteristic curve (ROC) curve was 0.742, P=0.005. Conclusion: LP-PL-A2 is of diagnostic value in OPBR combined with gallbladder cholesterol deposition.
Collapse
Affiliation(s)
- H L Zhang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - Y K Xiang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - H Hu
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - C Zhang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - X Y Kong
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - F Z Tian
- General Surgery Center of the Western Theater General Hospital,Chengdu 610083, China
| | - X B Da
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - C Qiu
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - B N Lyu
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - Y B Wang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - Y L Yang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| |
Collapse
|
15
|
Xiang YK, Zhang C, Yang YL, Hu H, Huang AH, Zhao G, Cai JL, Xu AA, Tian FZ, Qiu C, Kong XY, Da XB, Lyu BN, Zhang HL. [Clinical analysis of the correlation between gallbladder adenomyomatosis and occult pancreaticobiliary reflux]. Zhonghua Yi Xue Za Zhi 2023; 103:1230-1235. [PMID: 37087407 DOI: 10.3760/cma.j.cn112137-20220831-01843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/24/2023]
Abstract
Objective: To explore the association between gallbladder adenomyomatosis (GA) and occult pancreaticobiliary reflux (OPBR). Methods: A total of 81 patients with GA who underwent cholecystectomy in Shanghai East Hospital from December 2020 to January 2022 were enrolled, including 48 cases of fundal type, 28 cases of segmental type and 5 cases of diffuse type. Patient's intraoperative bile was coltected and tested for amylase. According to gallbladder bile amylase level, patients were divided into OPBR group (bile amylase>110 U/L) and the control group (bile amylase≤110 U/L). Results: Among 81 patients, 32 were male and 49 were female, and aged (49.1±13.2) years; there were 66 cases in control group, including 27 males and 39 females, and aged (50.0±12.9)years; there were 15 patients in the OPBR group, including 5 males and 10 females, and aged (45.1±14.2) years. In terms of the clinical features of the two groups, there was no significant difference (all P>0.05), except for a significant increase in biliary amylase in the OPBR group compared with the control group (P<0.001). However, the incidence of OPBR was significantly different in the three types of GA, with a lower incidence of OPBR in the fundal type (10.4%, 5/48) than in the segmental type (28.6%, 8/28) and diffuse type (2/5) (P=0.038). In addition, segmental GA was more likely to be combined with gallbladder stones (85.7%, 24/28) than fundal GA (58.3%, 28/48) and diffuse GA (3/5) (P=0.031). Univariate and multivariate logistic regression analyses showed OPBR [OR (95%CI)=3.410 (1.010 to 11.513), P=0.048] and combined gallbladder stones [OR (95%CI)=2.974 (1.011 to 8.745), P=0.048] indepenclently correlated with segmental and diffuse GA. Conclusions: The incidence of OPBR is higher in segmental and diffuse GA, and gallstones and OPBR are independently associated with the occurrence of segmental and diffuse GA. These results suggest that OPBR may be the initiating factor for the occurrence and carcinogenesis of segmental and diffuse GA.
Collapse
Affiliation(s)
- Y K Xiang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - C Zhang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - Y L Yang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - H Hu
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - A H Huang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - G Zhao
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - J L Cai
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - A A Xu
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - F Z Tian
- General Surgery Center of the Western Theater General Hospital, Chengdu 610083, China
| | - C Qiu
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - X Y Kong
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - X B Da
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - B N Lyu
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| | - H L Zhang
- Center of Gallbladder Disease, Shanghai East Hospital, Institute of Gallstone Disease, School of Medicine, Tongji University, Shanghai 200120, China
| |
Collapse
|
16
|
Zhang CF, Chen H, Yang CY, Song SS, Xu DZ, Zhang HL. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features originating in the rectum: report of a case]. Zhonghua Bing Li Xue Za Zhi 2023; 52:414-416. [PMID: 36973209 DOI: 10.3760/cma.j.cn112151-20220801-00666] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 03/29/2023]
Affiliation(s)
- C F Zhang
- Department of Pathology, the Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang 222000, China
| | - H Chen
- Department of Pathology, the Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang 222000, China
| | - C Y Yang
- Department of Pathology, the Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang 222000, China
| | - S S Song
- Department of Pathology, the Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang 222000, China
| | - D Z Xu
- Department of Gastroenterology, the Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang 222000, China
| | - H L Zhang
- Department of Pathology, the Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang 222000, China
| |
Collapse
|
17
|
Zhang HL, Yang CY, Li SQ, Zhang CF, Zhao YG, Zhang C, Chen H. [Transformation of breast micropapillary ductal carcinoma in situ into invasive micropapillary carcinoma after recurrence in chest wall: report of a case]. Zhonghua Bing Li Xue Za Zhi 2023; 52:175-177. [PMID: 36748142 DOI: 10.3760/cma.j.cn112151-20221003-00829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- H L Zhang
- Department of Pathology, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| | - C Y Yang
- Department of Pathology, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| | - S Q Li
- Department of Thyroid and Breast Surgery, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| | - C F Zhang
- Department of Pathology, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| | - Y G Zhao
- Department of Pathology, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| | - C Zhang
- Department of Pathology, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| | - H Chen
- Department of Pathology, the First People's Hospital of Lianyungang, Lianyungang 222002, China
| |
Collapse
|
18
|
Su HC, Min J, Song Y, Liu LL, Liu LN, Zhang HL. A bioequivalence study of trifluridine/tipiracil tablets in Chinese metastatic colorectal cancer patients under fed conditions. Cancer Chemother Pharmacol 2023; 91:167-177. [PMID: 36622402 DOI: 10.1007/s00280-022-04501-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Accepted: 12/18/2022] [Indexed: 01/10/2023]
Abstract
PURPOSE Colorectal cancer (CRC) is the second most common cause of cancer death worldwide. Trifluridine (FTD) remained at higher concentrations longer when administered along with tipiracil (TPI) compared with FTD alone. Lonsurf® is a combination formulation consisting of FTD and TPI. This study aimed to investigate the bioequivalence of FTD/TPI formulations in Chinese metastatic colorectal cancer (mCRC) patients. METHODS In this phase I, randomized, open-label, single-dose, two-sequence, four-cycle crossover study in mCRC patients, the bioequivalence of 60 mg (20 mg tablet, 3 tablets) of the test formulation and the reference formulation (Lonsurf®) was evaluated. Due to its high variability, the method of reference-scaled average bioequivalence (RSABE) was used to investigate the bioequivalence of the test and reference formulations. RESULTS Thirty-two patients were enrolled. 78.1% of the subjects were male, and the mean (standard deviation) age was 53.9 (SD = ± 9.0) years old. The time to reach the maximum plasma concentration (Tmax) was almost 2.0 h post-dose. The geometric least-squares mean ratios (GMRs) (test/reference) of Cmax and AUC0-t for FTD were 95.3% and 102.9%, respectively, with 90% confidence intervals (CIs) for the natural log-transformed ratios of Cmax and AUC0-t of 90.0-100.9% and 99.9-105.9%, while the GMRs of Cmax and AUC0-t for TPI were 95.7% and 100.7%, respectively, with 90% CIs of 90.5-101.2% and 97.0-104.7%. In addition, the GMRs of Cmax and AUC0-t for FTD's major metabolite, trifluorothymine (FTY), were 94.8 (90% CI 90.3-99.5%) and 99.33 (90% CI 96.9-101.9%), respectively. These were in accord with the FDA bioequivalence definition interval of 80-125%. CONCLUSION The test and reference FTD/TPI formulations were bioequivalent in Chinese mCRC patients under fed conditions.
Collapse
Affiliation(s)
- Hai-Chuan Su
- Department of Oncology, The Second Affiliated Hospital of Air Force Medical University, 1 Xinsi Road, Xi'an, 710038, People's Republic of China
| | - Jie Min
- Department of Oncology, The Second Affiliated Hospital of Air Force Medical University, 1 Xinsi Road, Xi'an, 710038, People's Republic of China
| | - Yang Song
- Department of Oncology, The Second Affiliated Hospital of Air Force Medical University, 1 Xinsi Road, Xi'an, 710038, People's Republic of China
| | - Li-Li Liu
- Department of Oncology, The Second Affiliated Hospital of Air Force Medical University, 1 Xinsi Road, Xi'an, 710038, People's Republic of China
| | - Lin-Na Liu
- Department of Pharmacy, The Second Affiliated Hospital of Air Force Medical University, 1 Xinsi Road, Xi'an, 710038, People's Republic of China.
| | - He-Long Zhang
- Department of Oncology, The Second Affiliated Hospital of Air Force Medical University, 1 Xinsi Road, Xi'an, 710038, People's Republic of China.
| |
Collapse
|
19
|
Cheema P, Cho BC, Freitas H, Provencio M, Chen YM, Kim SW, Wu YL, Passaro A, Martin C, Tiseo M, Chang GC, Park K, Solomon B, Burghuber O, Laskin J, Wang Z, Lee SY, Hu Y, Vansteenkiste J, Zhang HL, Hanrahan E, Geldart T, Taylor R, Servidio L, Li J, Marinis FD. A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data. Future Oncol 2023; 19:61-75. [PMID: 36656302 DOI: 10.2217/fon-2022-0919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
Aim: Report the final analysis from ASTRIS, the largest real-world study of second-/later-line osimertinib in advanced/metastatic EGFR T790M non-small-cell lung cancer (NSCLC). Methods: Patients with advanced/metastatic EGFR T790M NSCLC and prior EGFR-TKI treatment, received once-daily osimertinib 80 mg. Primary end point: overall survival (OS); secondary end points: progression-free survival (PFS), time-to-treatment discontinuation (TTD) and response rate. Safety was also recorded. Results: In 3014 patients, median OS: 22.8 months (21.6-23.8), median PFS: 11.1 months (11.0-12.0), median TTD: 13.5 months (12.6-13.9), and response rate: 57.3% (55.5-59.2). All end points reported with 95% CIs . Numerically longer median OS was observed in patients with baseline WHO performance status <2 versus 2 (24.0 vs 11.1 months) and those without versus with brain/leptomeningeal metastases (25.4 vs 18.0 months). No new safety signals were identified. Conclusion: Second-/later-line osimertinib demonstrated real-world clinical benefit and safety in advanced/metastatic EGFR T790M NSCLC. Clinical Trial Registration: NCT02474355 (ClinicalTrials.gov).
Collapse
Affiliation(s)
- Parneet Cheema
- William Osler Health System, University of Toronto, Toronto, ON, L6R 3J7, Canada
| | - Byoung Chul Cho
- Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea
| | - Helano Freitas
- Department of Medical Oncology, AC Camargo Cancer Center, São Paulo, 01509-001, Brazil
| | - Mariano Provencio
- Department of Oncology, Hospital Universitario Puerta de Hierro, Majadahonda, IDHIPSA, Universidad Autónoma de Madrid, 28222, Madrid, Spain
| | - Yuh Min Chen
- Department of Chest Medicine, Taipei Veterans General Hospital, & School of Medicine, National Yang-Ming Medical University, 112, Taipei, Taiwan
| | - Sang-We Kim
- Department of Oncology, Brain Tumor Center, Center for Personalized Cancer Medicine, Lung Cancer Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Republic of Korea
| | - Yi-Long Wu
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, & Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou, 510080, China
| | - Antonio Passaro
- Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, 71013, Italy
| | - Claudio Martin
- Department of Oncology, Instituto Alexander Fleming, Buenos Aires, C1426, Argentina
| | - Marcello Tiseo
- Department of Medicine & Surgery, University of Parma, & Medical Oncology Unit, University Hospital of Parma, Via Gramsci, 14, Parma, 43126, Italy
| | - Gee-Chen Chang
- School of Medicine, & Institute of Medicine, Chung Shan Medical University, Division of Pulmonary Medicine, Taichung, 40201, Taiwan.,Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, 40201, Taiwan.,Department of Internal Medicine, Division of Chest Medicine, Taichung Veterans General Hospital, Taichung, 40705, Taiwan
| | - Keunchil Park
- Division of Hematology/Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea
| | - Benjamin Solomon
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia
| | - Otto Burghuber
- Department of Respiratory & Critical Care Medicine, & Ludwig Boltzmann Institute of COPD & Respiratory Epidemiology, Otto Wagner Hospital, & Sigmund Freud University Medical School, Vienna, 1140, Austria
| | - Janessa Laskin
- Division of Medical Oncology, BC Cancer, Vancouver, V5Z 4E6, Canada.,Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, V6T 1Z4, Canada
| | - Ziping Wang
- Department of Thoracic Medical Oncology, Beijing Cancer Hospital, Beijing, 100142, People's Republic of China
| | - Sung Yong Lee
- Department of Internal Medicine, Division of Pulmonary, Allergy, & Critical Care Medicine, Korea University Guro Hospital, Seoul, 08308, Republic of Korea
| | - Yanping Hu
- Department of Thoracic Oncology, Hubei Cancer Hospital, Wuhan, 430079, People's Republic of China
| | - Johan Vansteenkiste
- Respiratory Oncology Unit, University Hospitals KU Leuven, Herestraat 49, B-3000, Leuven, Belgium
| | - He-Long Zhang
- Department of Oncology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710024, People's Republic of China
| | - Emer Hanrahan
- Department of Medical Oncology, St Vincent's University Hospital, & Cancer Trials Ireland, Dublin, D04 T6F4, Ireland
| | - Thomas Geldart
- Department of Oncology, University Hospitals Dorset, Bournemouth, BH7 7DW, UK
| | - Rosemary Taylor
- Biometrics & Information Sciences, AstraZeneca, Cambridge, CB2 0AA, UK
| | - Leslie Servidio
- Global Medical Affairs, Oncology Business Unit, AstraZeneca, Gaithersburg, MD 20878, USA
| | - Jingyi Li
- Global Medical Affairs, Oncology Business Unit, AstraZeneca, Gaithersburg, MD 20878, USA
| | - Filippo de Marinis
- Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, 71013, Italy
| |
Collapse
|
20
|
Ma C, Qi X, Wei YF, Li Z, Zhang HL, Li H, Yu FL, Pu YN, Huang YC, Ren YX. Amelioration of ligamentum flavum hypertrophy using umbilical cord mesenchymal stromal cell-derived extracellular vesicles. Bioact Mater 2023; 19:139-154. [PMID: 35475028 PMCID: PMC9014323 DOI: 10.1016/j.bioactmat.2022.03.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2022] [Revised: 03/29/2022] [Accepted: 03/30/2022] [Indexed: 11/09/2022] Open
Abstract
Ligamentum flavum (LF) hypertrophy (LFH) has been recognised as one of the key contributors to lumbar spinal stenosis. Currently, no effective methods are available to ameliorate this hypertrophy. In this study, human umbilical cord mesenchymal stromal cell-derived extracellular vesicles (hUCMSC-EVs) were introduced for the first time as promising vehicles for drug delivery to treat LFH. The downregulation of miR-146a-5p and miR-221-3p expressions in human LF tissues negatively correlated with increased LF thickness. The hUCMSC-EVs enriched with these two miRNAs significantly suppressed LFH in vivo and notably ameliorated the progression of transforming growth factor β1(TGF-β1)-induced fibrosis in vitro after delivering these two miRNAs to mouse LF cells. The results further demonstrated that miR-146a-5p and miR-221-3p directly bonded to the 3′-UTR regions of SMAD4 mRNA, thereby inhibiting the TGF-β/SMAD4 signalling pathway. Therefore, this translational study determined the effectiveness of a hUCMSC-EVs-based approach for the treatment of LFH and revealed the critical target of miR-146a-5p and miR-221-3p. Our findings provide new insights into promising therapeutics using a hUCMSC-EVs-based delivery system for patients with lumbar spinal stenosis. The downregulation of miR-146a-5p and miR-221-3p expressions were negatively correlated with the development of LFH. MiR-146a-5p and miR-221-3p enriched in hUCMSC-EVs prevent the fibrosis of LF by targeting SMAD4. hUCMSC-EVs are effective as bioactive vehicles to ameliorate the progression of LFH. hUCMSC-EVs-based delivery system is a promising therapy for the patients with lumbar spinal stenosis.
Collapse
|
21
|
Song YH, Xu F, Wang D, Zhang HL, Li X, Hu YL, Wang C. [A case of multifocal extramedullary hematopoiesis misdiagnosed as primary liver cancer concomitant with multiple systemic metastases]. Zhonghua Gan Zang Bing Za Zhi 2022; 30:991-993. [PMID: 36299195 DOI: 10.3760/cma.j.cn501113-20210319-00134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Affiliation(s)
- Y H Song
- Department of Hepatobiliary and Pancreatic Medicine, the First Hospital of Jilin University, Changchun 130000, China
| | - F Xu
- Department of Hepatobiliary and Pancreatic Medicine, the First Hospital of Jilin University, Changchun 130000, China
| | - D Wang
- Department of Hepatobiliary and Pancreatic Medicine, the First Hospital of Jilin University, Changchun 130000, China
| | - H L Zhang
- Department of Hepatobiliary and Pancreatic Medicine, the First Hospital of Jilin University, Changchun 130000, China
| | - X Li
- Department of Hepatobiliary and Pancreatic Medicine, the First Hospital of Jilin University, Changchun 130000, China
| | - Y L Hu
- Department of Hepatobiliary and Pancreatic Medicine, the First Hospital of Jilin University, Changchun 130000, China
| | - C Wang
- Department of Hepatobiliary and Pancreatic Medicine, the First Hospital of Jilin University, Changchun 130000, China
| |
Collapse
|
22
|
Jiao J, Yuan LL, Li T, Wu H, Gu GZ, Chen GS, Zhang HL, Yu SF. [A case-control study on the relationship between DNA methylation and occupational noise hearing loss]. Zhonghua Yu Fang Yi Xue Za Zhi 2022; 56:1087-1094. [PMID: 35922236 DOI: 10.3760/cma.j.cn112150-20210917-00905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objective: To explore the relationship between DNA methylation and occupational noise-induced hearing loss. Methods: A case-control study was conducted. People with hearing loss induced by occupational noise were recruited as the case group and those with normal hearing but still exposed to occupational noise were recruited as the control group. A total of 60 participants were included, of which 30 participants were in the case group and 30 in the control group. The methylation level was detected by 850k genome-wide DNA methylation chip technology. The significance of differential methylated position (DMP) was tested by R-packet 'Champ'. The differential methylated region (DMR) was analyzed by using Champ's Bumphunter algorithm. Cluster profiler was used to analyze the gene list for GO and KEGG pathway enrichment. Results: There was significant difference between two groups in binaural high-frequency average hearing threshold (P<0.05), but there was no significant difference in age, smoking, drinking, hypertension, physical exercise and cumulative noise exposure. The results of DMP and DMR analysis showed that 713875 sites were detected in the case group and the control group, and 439 methylation sites with significant difference, accounting for 0.06%; 650 regions were detected, and 72 methylation regions with significant differences, accounting for 11.08%. Compared with the control group, the results of GO enrichment analysis showed that the case group had statistically significant differences in four pathways: axogenesis of projection neurons in the central nervous system, neuronal development in the central nervous system, axogenesis of neurons in the central nervous system and neuronal differentiation in the central nervous system. KEGG enrichment analysis showed that there were significant differences in sphingolipid metabolism, aldosterone synthesis and secretion, primary bile acid biosynthesis pathway between the case group and the control group. Conclusion: The occurrence of occupational noise-induced hearing loss may be related to the regulation of gene expression related to axogenesis of projection neurons in the central nervous system, development of neurons in the central nervous system, axogenesis of neurons in the central nervous system, differentiation of neurons in the central nervous system, sphingolipid metabolism, aldosterone synthesis and secretion, primary bile acid biosynthesis and gene methylation related to metabolism.
Collapse
Affiliation(s)
- J Jiao
- Department of Occupational Health, The Third People's Hospital of Henan Province (Henan Hospital for Occupational Diseases),Zhengzhou 450052, China
| | - L L Yuan
- Department of Occupational Health,School of Public Health, Zhengzhou University, Zhengzhou 450001, China
| | - T Li
- Department of Occupational Health,School of Public Health, Zhengzhou University, Zhengzhou 450001, China
| | - H Wu
- Department of Administrative Office, The Third People's Hospital of Henan Province (Henan Hospital for Occupational Diseases),Zhengzhou 450052, China
| | - G Z Gu
- Department of Administrative Office, The Third People's Hospital of Henan Province (Henan Hospital for Occupational Diseases),Zhengzhou 450052, China
| | - G S Chen
- Department of Medical Examination Center, Wugang Institute for Occupational Health, Pingdingshan 467036, China
| | - H L Zhang
- Department of Medical Examination Center, Wugang Institute for Occupational Health, Pingdingshan 467036, China
| | - S F Yu
- Department of Public Health and Health Management, Henan Medical College, Zhengzhou 451191, China
| |
Collapse
|
23
|
Yu Y, Zhang HL, Shang Y. [Whether extracorporeal membrane oxygenation can be used in adult patients with sepsis and septic shock?]. Zhonghua Yi Xue Za Zhi 2022; 102:1899-1903. [PMID: 35768388 DOI: 10.3760/cma.j.cn112137-20220209-00264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Sepsis is a critical medical problem that needs to be solved urgently worldwide. Some patients with sepsis have refractory shock or/and severe respiratory failure, which may require supporting with extracorporeal membrane oxygenation (ECMO). Particularly, it is important to choose the optimal mode and grasp the optimal timing of the initiation in the experienced ECMO center. The choice of mode is mainly based on the patient's condition of oxygenation and hemodynamics. During the management of ECMO support, some issues like blood flow, anticoagulation and therapy of antibiotics should be noted. Thus far, the research of ECMO in adult patients with sepsis and septic shock are mainly retrospective, observational and with small sample size. Further exploration is needed in the future.
Collapse
Affiliation(s)
- Y Yu
- Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - H L Zhang
- Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Y Shang
- Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| |
Collapse
|
24
|
Ke Y, Liao CG, Zhao ZQ, Li XM, Lin RJ, Yang L, Zhang HL, Kong LM. Combining a CDK4/6 Inhibitor With Pemetrexed Inhibits Cell Proliferation and Metastasis in Human Lung Adenocarcinoma. Front Oncol 2022; 12:880153. [PMID: 35686110 PMCID: PMC9172583 DOI: 10.3389/fonc.2022.880153] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2022] [Accepted: 04/25/2022] [Indexed: 12/17/2022] Open
Abstract
Background Recent clinical trials of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) in human lung adenocarcinoma (LUAD) have not achieved satisfactory results. The disappointing results of single-drug treatments have prompted studies about synergistic therapies of CDK4/6i with other drugs. We aimed to test the anti-tumor effect of ribociclib (a CDK4/6i) combined with pemetrexed on LUAD and the potential mechanisms. Methods Cell lines were exposed to ribociclib and pemetrexed at different doses. Antitumor effects were measured using growth inhibition. Cell cycle distribution and apoptosis were evaluated using flow cytometry. Cell migration and invasion were measured using wound healing and transwell invasion assays, respectively. The expression levels of proteins were analyzed using western blotting. Mice xenograft models were used for validation in vivo. Results Synergism was associated with a combination of cell cycle effects from both agents. Cell cycle analysis revealed that pemetrexed blocked cells in the S phase, whereas ribociclib arrested cells in the G1 phase. Concomitant treatment with pemetrexed and ribociclib resulted in a significantly stronger antitumor ability than treatment alone. We also found that ribociclib strongly enhanced the pro-apoptotic activity of pemetrexed via the caspase/bcl-2 signaling pathway. In addition, we report for the first time that combination treatment with ribociclib and pemetrexed significantly inhibits the migration and invasion of LUAD cells. Conclusions Combining ribociclib and pemetrexed showed a powerful ability to inhibit cancer proliferation, invasion, and metastasis, and it holds potential as a novel effective combinative therapy for patients with LUAD.
Collapse
Affiliation(s)
- Yuan Ke
- Department of Oncology, Second Affiliated Hospital of Air Force Military Medical University, Xi'an, China
| | - Cheng-Gong Liao
- Department of Oncology, Second Affiliated Hospital of Air Force Military Medical University, Xi'an, China
| | - Zheng-Qing Zhao
- Department of Neurology, Changzheng Hospital, Naval Medical University, Shanghai, China
| | - Xiao-Min Li
- Department of Cell Biology, National Translational Science Center for Molecular Medicine, Air Force Military Medical University, Xi'an, China
| | - Rong-Jie Lin
- State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Air Force Military Medical University, Xi'an, China
| | - Long Yang
- Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Military Medical University, Xi'an, China
| | - He-Long Zhang
- Department of Oncology, Second Affiliated Hospital of Air Force Military Medical University, Xi'an, China
| | - Ling-Min Kong
- Department of Cell Biology, National Translational Science Center for Molecular Medicine, Air Force Military Medical University, Xi'an, China
| |
Collapse
|
25
|
Zhang HL, Wang ML, Yi LZ, Högger P, Arroo R, Bajpai VK, Prieto MA, Chen XJ, Simal-Gandara J, Cao H. Stability profiling and degradation products of dihydromyricetin in Dulbecco's modified eagle's medium. Food Chem 2022; 378:132033. [PMID: 35033717 DOI: 10.1016/j.foodchem.2021.132033] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Revised: 12/20/2021] [Accepted: 12/31/2021] [Indexed: 11/30/2022]
Abstract
Dihydromyricetin has shown many bioactivities in cell level. However, dihydromyricetin was found to be highly instable in cell culture medium DMEM. Here, the underlying degradation mechanism was investigated via UPLC-MS/MS analysis. Dihydromyricetin was mainly converted into its dimers and oxidized products. At lower temperature, dihydromyricetin in DMEM showed higher stability. Vitamin C increased the stability of dihydromyricetin in DMEM probably due to its high antioxidant potential.
Collapse
Affiliation(s)
- H L Zhang
- Institute of Chinese Medical Sciences, University of Macau, Macao, China.
| | - M L Wang
- Institute of Chinese Medical Sciences, University of Macau, Macao, China.
| | - L Z Yi
- Faculty of Agriculture and Food, Kunming University of Science and Technology, Kunming, Yunnan 650500, China.
| | - P Högger
- Institut für Pharmazie und Lebensmittelchemie, Universität Würzburg, 97074 Würzburg, Germany.
| | - R Arroo
- De Montfort University - Leicester School of Pharmacy, The Gateway, Leicester LE1 9BH, UK.
| | - V K Bajpai
- Department of Energy and Materials Engineering, Dongguk University-Seoul, 30 Pildong-ro 1-gil, Seoul 04620, Republic of Korea
| | - M A Prieto
- Department of Analytical Chemistry and Food Science, Faculty of Food Science and Technology, University of Vigo - Ourense Campus, E-32004 Ourense, Spain.
| | - X J Chen
- Institute of Chinese Medical Sciences, University of Macau, Macao, China.
| | - J Simal-Gandara
- Department of Analytical Chemistry and Food Science, Faculty of Food Science and Technology, University of Vigo - Ourense Campus, E-32004 Ourense, Spain.
| | - H Cao
- Department of Analytical Chemistry and Food Science, Faculty of Food Science and Technology, University of Vigo - Ourense Campus, E-32004 Ourense, Spain; College of Food Science and Technology, Guangdong Ocean University, Zhanjiang 524088, China
| |
Collapse
|
26
|
Liu HM, Fu Z, Zhang XB, Zhang HL, Bao YX, Wu XD, Shang YX, Zhao DY, Zhao SY, Zhang JH, Chen ZM, Liu EM, Deng L, Liu CH, Xiang L, Cao L, Zou YX, Xu BP, Dong XY, Yin Y, Hao CL, Hong JG. [Expert consensus on rational usage of nebulization treatment on childhood respiratory system diseases]. Zhonghua Er Ke Za Zhi 2022; 60:283-290. [PMID: 35385931 DOI: 10.3760/cma.j.cn112140-20220118-00059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Affiliation(s)
- H M Liu
- Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - Z Fu
- Department of Respiratory, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - X B Zhang
- Department of Respiratory Disease, Children's Hospital of Fudan University, Shanghai 201102, China
| | - H L Zhang
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Y X Bao
- Tongxing Children's Clinic, Shanghai 200433, China
| | - X D Wu
- Department of Respiratory,Xiamen Children's Hospital (Children's Hospital of Fudan University at Xiamen), Xiamen 361006, China
| | - Y X Shang
- Department of Pediatric Pulmonology, Shengjing Hospital of China Medical University, Shenyang 110136, China
| | - D Y Zhao
- Department of Respiratory Medicine, Children's Hospital of Nanjing Medical University, Nanjing 210008, China
| | - S Y Zhao
- Department No.2 of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - J H Zhang
- Department of Pediatric Respiratory, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
| | - Z M Chen
- Department of Pulmonology, the Children's Hospital, Zhejiang University School of Medicine, Hangzhou 310052, China
| | - E M Liu
- Department of Respiratory, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - L Deng
- Department of Respiratory,Guangzhou Women and Children's Medical Center, Guangzhou 510623, China
| | - C H Liu
- Department of Allergy,Children's Hospital Capital Institute of Pediatrics, Beijing 100020, China
| | - L Xiang
- Department of Allergic Medicine, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - L Cao
- Department of Allergy,Children's Hospital Capital Institute of Pediatrics, Beijing 100020, China
| | - Y X Zou
- Department of Respiratory, Tianjin Children's Hospital, Tianjin 300134, China
| | - B P Xu
- Department of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - X Y Dong
- Department of Pulmonology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - Y Yin
- Department of Respiratory Medicine, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200062, China
| | - C L Hao
- Department of Respiratory,Children's Hospital of Soochow University, Suzhou 215002, China
| | - J G Hong
- Department of Pediatrics, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
| |
Collapse
|
27
|
Zhang HL, Chen J, Huang WX, Tan PQ, Wang JQ, Xie L, Zhong WS, Huang PX, Tan HL, Bao RH. [Classification and reconstruction of complex defects after lateral facial tumor surgery]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2021; 56:1144-1149. [PMID: 34749452 DOI: 10.3760/cma.j.cn115330-20210623-00370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the classification and reconstruction strategy of defects in lateral face region after operation of malignant tumors. Methods: Eighteen cases with the reconstruction of complicated defects after resection of tumors in the region of lateral face from January 2015 to January 2018 in Hunan Cancer Hospital were retrospectively reviewed. There were 14 males and 4 females, aged from 32 to 68 years. According to the presence or absence of bony scaffold, complicated defects were divided into two main categories: soft tissue perforating defects and soft tissue defects combined with bony scaffold defects. All soft tissue perforating defects in 5 cases were repaired with free anterolateral femoral flaps. Among 13 cases with soft tissue plus bony scaffold defects, 3 were repaired with free fibular flaps, 6 with free fibular flaps combined with free anterolateral femoral flaps, and 4 with chimeric deep circumflex iliac artery perforator flaps combined with anterolateral femoral flaps. Results: All flaps survived well. Two patients complicated with fistula in floor of mouth, but the wound healed after dressing change. Transoral feeding was resumed within 2 weeks after surgery in all patients. One year follow-up evaluation showed that 14 cases had symmetrical face and 10 cases had mouth opening more than 3 transverse fingers. After 36-50 months of follow-up, 6 patients died, with an overall 3-year survival rate of 66.7%. Conclusion: The classification of defects with or without bony stent loss is conducive to the overall repair design, the recovery of facial contour stent, the effective fill of dead space and the maintain of residual occlusal relationship. Good reconstruction results require a multi flap combination of osteocutaneous and soft tissue flaps.
Collapse
Affiliation(s)
- H L Zhang
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - J Chen
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - W X Huang
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - P Q Tan
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - J Q Wang
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - L Xie
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - W S Zhong
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - P X Huang
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - H L Tan
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| | - R H Bao
- Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha 410013, China
| |
Collapse
|
28
|
Wang XD, Liu X, Wu T, Yang Y, Qi SN, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhu Y, Cao JZ, Wu JX, Zhu SY, Shi M, Su H, Zhang XM, Zhang HL, Huang HQ, Zhang YJ, Song YQ, Zhu J, Wang Y, Li YX. [Outcome of radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type]. Zhonghua Zhong Liu Za Zhi 2021; 43:1105-1113. [PMID: 34695903 DOI: 10.3760/cma.j.cn112152-20200924-00851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the prognosis and determine the failure patterns after radiotherapy for low-risk early-stage patients with extranodal NK/T-cell lymphoma, nasal-type (ENKTCL). Methods: A total of 557 patients from 2000-2015 with low-risk early-stage ENKTCL who received radiotherapy (RT) with or without chemotherapy (CT) from China Lymphoma Collaborative Group were retrospectively reviewed. Among them, 427 patients received combined modality therapy, whereas 130 patients received RT alone. Survivals were calculated by Kaplan-Meier method and compared with Log-rank test. Overall survival (OS) was compared with age and sex-matched general Chinese population using expected survival and standardized mortality ratio (SMR). Cox stepwise regression model was used for multivariate analysis. Results: The 5-year OS and progression-free survival (PFS) were 87.2% and 77.2%. The SMR was 3.59 (P<0.001) at 1 year after treatment, whereas it was 1.50 at 4 years after treatment, without significant difference between ENKTCL group and country-matched general population (P=0.146). Compared with RT alone, CMT did not result in significantly superior 5-year OS (87.0% vs 87.4%, P=0.961) or PFS (76.1% vs 80.7%, P=0.129). Local failure (11.5%, 64/557) and distant failure (10.8%, 60/557) were the main failure modes, while regional failure was rare (2.9%, 16/557). The 5-year locoregional control rate (LRC) was 87.2% for the whole group, with 89.5% for ≥50 Gy versus 73.7% for <50 Gy (P<0.001). Radiotherapy dose was an independent factor affecting LRC(P<0.05). Conclusions: Radiotherapy achieves a favorable prognosis in patients with low-risk early-stage ENKTCL. The incidence of either locoregional or distant failure is low. Radiation dose still is an important prognostic factor for LRC.
Collapse
Affiliation(s)
- X D Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - X Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - T Wu
- Department of Radiation Oncology, Affiliated Hospital of Guizhou Medical University/Guizhou Cancer Hospital, Guiyang 550000, China
| | - Y Yang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - S N Qi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| | - X He
- Department of Radiation Oncology, Jiangsu Cancer Hospital/Nanjing Medical University Affiliated Cancer Hospital, Nanjing 210009, China
| | - L L Zhang
- Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, China
| | - G Wu
- Department of Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430023, China
| | - B L Qu
- Department of Radiation Oncology, The General Hospital of Chinese People's Liberation Army, Beijing 100853, China
| | - L T Qian
- Department of Radiation Oncology, the First Affiliated Hospital of University of Science and Technology of China/Anhui Provincial Hospital, Hefei 230001, China
| | - X R Hou
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - F Q Zhang
- Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
| | - X Y Qiao
- Department of Radiation Oncology, Hebei Cancer Hospital/the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - H Wang
- Department of Radiation Oncology, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China
| | - G F Li
- Department of Radiation Oncology, Beijing Hospital, Beijing 100730, China
| | - Y Zhu
- Department of Radiation Oncology, Zhejiang Cancer Hospital/Cancer Hospital of The University of Chinese Academy of Sciences, Hangzhou 310022, China
| | - J Z Cao
- Department of Radiation Oncology, Shanxi Cancer Hospital and the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - J X Wu
- Department of Radiation Oncology, Fujian Provincial Cancer Hospital/Affiliated Cancer Hospital of Fujian Medical University, Fuzhou 350014, China
| | - S Y Zhu
- Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha 410013, China
| | - M Shi
- Department of Radiation Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China
| | - H Su
- Department of Oncology, the Fifth Medical Center of PLA General Hospital, Affiliated Hospital of PLA Academy of Military Medical Sciences, Beijing 100071, China
| | - X M Zhang
- Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy/Tianjin Medical University Cancer Institute & Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - H L Zhang
- Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy/Tianjin Medical University Cancer Institute & Hospital/National Clinical Research Center for Cancer, Tianjin 300060, China
| | - H Q Huang
- Departments of Radiation Oncology, State Key Laboratory of Oncology in South China/Sun Yat-sen University Cancer Center/Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
| | - Y J Zhang
- Departments of Medical Oncology, State Key Laboratory of Oncology in South China/Sun Yat-sen University Cancer Center/Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China
| | - Y Q Song
- Department of Radiation Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)/Peking University Cancer Hospital & Institute, Beijing 100142, China
| | - J Zhu
- Department of Radiation Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)/Peking University Cancer Hospital & Institute, Beijing 100142, China
| | - Y Wang
- Department of Radiation Oncology, Chongqing Cancer Hospital, Chongqing 400000, China
| | - Y X Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
| |
Collapse
|
29
|
Dai WR, Yin BZ, Li X, Cai HQ, Zhang HL, Liu WF. [Analysis of chronic obstructive pulmonary disease screening questionnaire and pulmonary function test among migrant workers exposed to dust]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2021; 39:582-585. [PMID: 34488265 DOI: 10.3760/cma.j.cn121094-20200330-00163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To analyze the application of Chronic Obstructive Pulmonary Disease (COPD) Screening Questionnaire and pulmonary function test in dust-exposed migrant workers. Methods: In May 2019, 149 cases of dust exposed migrant workers were selected as the research subjects through the free clinic in the countryside. COPD Screening Questionnaire and lung function test were carried out to analyze the high-risk groups and the influencing factors of positive pulmonary function test results. Results: Among 149 cases of dust-exposed migrant workers, 107 (71.8%) were positive for questionnaire screening, 73 (49.0%) were positive for pulmonary function test, 75 (50.3%) were diagnosed with coal worker's pneumoconiosis, and 101 (67.8%) were diagnosed with lung function injury. The positive rate of pulmonary function of migrant workers with positive questionnaire screening results was significantly higher than that of those with negative results (P<0.05) . The results of multivariate analysis showed that compared with non-pneumoconiosis, the risk of positive pulmonary function test results was higher in dust-exposed migrant workers with stage Ⅲ pneumoconiosis (OR=16.462, 95%CI: 3.390-79.946; P<0.01) . Compared with non-smoking, the risks of positive pulmonary function test results of dust-exposed migrant workers with smoking index of 11-20 package years and >20 package years were higher (OR=19.814, 95%CI: 3.854-101.883; OR=9.733, 95%CI: 2.310-41.008; P<0.01) . Conclusion: The risk of COPD in dust-exposed migrant workers is high, so we should strengthen the early examination of the high pneumoconiosis stage and smoking population. The screening questionnaire can better screen out the high-risk groups of COPD, and it can be used as a basic screening tool.
Collapse
Affiliation(s)
- W R Dai
- Hunan Prevention and Treatment Center for Occupational Diaseases, Changsha 410007, China
| | - B Z Yin
- Xinhua Center for Disease Control and Prevention, Loudi 417600, China
| | - X Li
- Hunan Prevention and Treatment Center for Occupational Diaseases, Changsha 410007, China
| | - H Q Cai
- Xinhua Center for Disease Control and Prevention, Loudi 417600, China
| | - H L Zhang
- Xinhua Center for Disease Control and Prevention, Loudi 417600, China
| | - W F Liu
- Hunan Prevention and Treatment Center for Occupational Diaseases, Changsha 410007, China
| |
Collapse
|
30
|
Yang X, Chen S, Qi Y, Xu XY, Guan X, Yang YC, Liu YX, Guo YH, Gong WC, Gao YN, Wang XH, Li W, Li LF, Fu K, Zhang HL, Meng B. [Research of prognostic immunophenotypes in 163 patients of diffuse large B-cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi 2021; 42:487-494. [PMID: 34384155 PMCID: PMC8295611 DOI: 10.3760/cma.j.issn.0253-2727.2021.06.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
目的 筛选并分析与弥漫大B细胞淋巴瘤(DLBCL)预后相关的免疫表型,探究其预后价值。 方法 选取天津医科大学肿瘤医院2011年1月至2016年12月收治的163例DLBCL患者,免疫组织化学染色检测DLBCL常见免疫表型,COX模型探索独立于国际预后指数(IPI)影响总生存(OS)与无进展生存(PFS)的免疫表型,并分析其两两联合表达对预后的影响。 结果 多因素分析显示BCL6阴性(PFS:HR=1.652,95% CI 1.030~2.649,P=0.037)、P53阳性(OS:HR=1.842,95% CI 1.008~3.367,P=0.047)、BCL2强阳性(OS:HR=2.102,95%CI 1.249~3.537,P=0.005;PFS:HR=2.126,95% CI 1.312~3.443,P=0.002)是DLBCL中独立于IPI的预后不良因素。亚组分析显示,在年龄≤60岁组患者中BCL6阴性(PFS:HR=2.042,95%CI 1.021~4.081,P=0.043)、P53阳性(OS:HR=3.069,95% CI 1.244~7.569,P=0.015)和BCL2强阳性(OS:HR=2.433,95% CI 1.165~5.082,P=0.018;PFS:HR=3.209,95%CI 1.606~6.410,P=0.001)对预后影响显著;在IPI 0~2分亚组患者中,BCL6阴性(OS:HR=2.467,95%CI 1.322~4.604,P=0.005;PFS:HR=2.248,95%CI 1.275~3.965,P=0.005)和BCL2强阳性(PFS:HR=2.045,95%CI 1.119~3.735,P=0.020)对预后影响显著。BCL6和BCL2强阳性的联合表达与DLBCL的预后相关(P=0.005和P<0.001),BCL6阳性/BCL2非强阳性(86例)预后最好[3年OS率(71.6±4.9)%,3年PFS率(67.0±5.1)%],BCL6阴性/BCL2强阳性(10例)预后最差[3年OS率(20.0±12.6)%,3年PFS率(10.0±9.5)%];BCL6、P53的联合表达与DLBCL的预后差异无统计学意义(P=0.061和P=0.089),但生存曲线显示BCL6阳性/P53阴性的病例(98例)预后较好[3年OS率(70.6±4.7)%,3年PFS率(64.6±4.9)%];BCL2强阳性、P53的联合表达与DLBCL的预后显著相关(P<0.001和P<0.001),BCL2强阳性/P53阳性的病例(5例)预后最差(3年OS率和PFS率均为0);无论BCL6与P53表达如何,BCL2强阳性的病例预后均比非强阳性病例差。 结论 BCL6阴性、P53阳性、BCL2强阳性三种免疫表型单独及联合表达对DLBCL尤其是年龄≤60岁和IPI 0~2分患者的预后预测具有一定价值。
Collapse
Affiliation(s)
- X Yang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - S Chen
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y Qi
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - X Y Xu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - X Guan
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y C Yang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y X Liu
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y H Guo
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - W C Gong
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - Y N Gao
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| | - X H Wang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - W Li
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - L F Li
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - K Fu
- Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York, USA
| | - H L Zhang
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China
| | - B Meng
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center of Cancer, Tianjin 300060, China Department of Pathology, Tianjin Medical University Cancer Institute andHospital, Tianjin 300060, China
| |
Collapse
|
31
|
Wang QY, Zhang HL, Ren Z, Liu YB, Ji JY, Huang J. Transcriptome Sequencing Analysis of Chrysomyia Megacephala Pupae in Different Growing Periods. Fa Yi Xue Za Zhi 2021; 37:318-324. [PMID: 34379899 DOI: 10.12116/j.issn.1004-5619.2020.401214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 12/31/2020] [Indexed: 11/30/2022]
Abstract
Abstract Objective To study the growth regulation, environmental adaption and epigenetic regulation of Chrysomyia Megacephala pupae, in order to obtain the transcriptome data of Chrysomyia Megacephala in different growing periods, and lay the foundation for forensic application. Methods The Chrysomyia Megacephala was cultivated and after pupation, 3 pupae were collected every 24 h from pupation to emergence, and stored at -80 ℃ for later use. High-throughput sequencing was performed by Illumina Hiseq 4000 and Unigenes were obtained. The Unigenes were compared by comparison tool BLAST from NCBI in databases such as NR, STRING, SWISS-PROT (including Pfam), GO, COG, KEGG in order to obtain the corresponding annotation information. The expression amount of Unigenes obtained by sequencing in Chrysomyia Megacephala in six different growing periods was calculated by FPKM method, and the discrepant genes were screened according to the following standards: the log2 multiple absolute value of FPKM expression amount between two different growing periods must be larger than 1 (log2|FC|>1), and the false discovery rate must be less than 0.05. Results When the mean temperature was 25.6 ℃, Chrysomyia Megacephala emerged 6 d after they pupated. A total of 43 408 pieces of Unigenes were obtained and their mean length was 905 bp, of which 32 500, 18 720, 13 542, 9 191 and 18 720 pieces were annotated by NR, SWISS-PORT, Pfam, STRING and KEGG databases. According to the discrepant gene analysis of pupae in two different growing periods, the number of genes with variants ranged from 801 to 5 307, and the total number of discrepant genes was 45 676. Conclusion The gene expressions of the transcriptome data of Chrysomyia Megacephala pupae in different growing periods are different. The results provided a good foundation for further research on the transcriptome changes in each period of the pupae of sarcosaprophagous flies and provided the basis for exploring the genes associated with the growth of Chrysomyia Megacephala pupae.
Collapse
Affiliation(s)
- Q Y Wang
- Department of Forensic Medicine, School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China
| | - H L Zhang
- Department of Forensic Medicine, School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China
| | - Z Ren
- Department of Forensic Medicine, School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China
| | - Y B Liu
- Department of Forensic Medicine, School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China
| | - J Y Ji
- Department of Forensic Medicine, School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China
| | - J Huang
- Department of Forensic Medicine, School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China
| |
Collapse
|
32
|
Wang YJ, Zhang HL, Li J, Bu P, Zhang F, Xi YF. [Expression of GATA3 and bcl-11b in peripheral T-cell lymphoma and their clinical significance]. Zhonghua Bing Li Xue Za Zhi 2021; 50:904-909. [PMID: 34344074 DOI: 10.3760/cma.j.cn112151-20201224-00955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the expression of GATA3 and bcl-11b in peripheral T-cell lymphoma (PTCL) and their correlation with clinicopathological features. Methods: The Oncomine and GEO databases were used for analyzing the expression levels of GATA3 and bcl-11b mRNA in PTCL. Immunohistochemistry was used to detect the expression of GATA3 and bcl-11b proteins in 127 cases of PTCL diagnosed at Shanxi Provincial Cancer Hospital from January 2010 to June 2020, as well as 40 cases of lymph node with reactive hyperplasia. Results: The data in Oncomine and GEO databases showed that the expression of GATA3 and bcl-11b mRNA in PTCL was lower than that in normal tissues (P<0.05). Immunohistochemistry showed that the positive rates of GATA3 in PTCL and lymph nodes with reactive hyperplasia were 60.6% (77/127) and 85.0% (34/40, P<0.05), respectively. The expression rates of bcl-11b in PTCL and lymph nodes with reactive hyperplasia were 55.1% (70/127) and 75.0% (30/40, P<0.05), respectively. The expression of GATA3 was related to the pathological classification of the patients with PTCL, and was inversely related to the Ann Arbor stage of the patient, while the expression of bcl-11b was inversely correlated with the IPI score of the patient (P<0.05). The expression of GATA3 and bcl-11b was related to the patients' age, gender, LDH level, and B symptoms. Other clinicopathological characteristics were irrelevant. Spearman correlation analysis shows that the expression of GATA3 protein was associated with that of bcl-11b protein in PTCL. Conclusion: GATA3 and bcl-11b are closely related to the prognosis of PTCL, and may be important factors involved in the occurrence and development of PTCL.
Collapse
Affiliation(s)
- Y J Wang
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030000, China
| | - H L Zhang
- Department of Pathology, Second Medical College of Shanxi Medical University, Taiyuan 030000, China
| | - J Li
- Department of Pathology, Shanxi Cancer Hospital, Taiyuan 030000, China
| | - P Bu
- Department of Pathology, Shanxi Cancer Hospital, Taiyuan 030000, China
| | - F Zhang
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030000, China
| | - Y F Xi
- Department of Pathology, Shanxi Cancer Hospital, Taiyuan 030000, China
| |
Collapse
|
33
|
Zhou YL, Liu JR, Yi QW, Chen LN, Han ZY, Xu CD, Liu SY, Hao CL, Liu J, Li QL, Wang LJ, Wang C, Che GH, Zhang YY, Tong L, Liu YQ, Zhao SY, Zheng YJ, Li S, Liu HM, Chang J, Zhao DY, Zou YX, Zhang XX, Nong GM, Zhang HL, Pan JL, Chen YN, Dong XY, Zhang YF, Wang YS, Yang DH, Lu Q, Chen ZM. [A multicenter retrospective study on the etiology of necrotizing pneumonia in children]. Zhonghua Er Ke Za Zhi 2021; 59:658-664. [PMID: 34333918 DOI: 10.3760/cma.j.cn112140-20210126-00072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the etiology of necrotizing pneumonia (NP) in children and the clinical characteristics of NP caused by different pathogens in China. Methods: A retrospective, case-control study was performed in children with NP who were admitted to 13 hospitals in China from January 2008 to December 2019. The demographic and clinical information, laboratory data, etiological and radiological findings were analyzed. The data were divided into three groups based on the following years: 2008-2011, 2012-2015 and 2016-2019, and the distribution characteristics of the pathogens in different period were compared. Meanwhile, the pathogens of pediatric NP in the southern and northern China were compared. And the clinical characteristics of the Mycoplasma pneumoniae (MP) NP and the bacterial NP were also compared. T-test or Mann-Whitney nonparametric test was used for comparison of numerical variables, and χ2 test was used for categorical variables. Results: A total of 494 children with NP were enrolled, the median ages were 4.7 (0.1-15.3) years, including 272 boys and 222 girls. Among these patients, pathogens were identified in 347 cases and the pathogen was unclear in the remaining 147 cases. The main pathogens were MP (238 cases), Streptococcus pneumoniae (SP) (61 cases), Staphylococcus aureus (SA) (51 cases), Pseudomonas aeruginosa (13 cases), Haemophilus influenzae (10 cases), adenovirus (10 cases), and influenza virus A (7 cases), respectively. MP was the most common pathogen in all three periods and the proportion increased yearly. The proportion of MP in 2016-2019 was significantly higher than that in 2012-2015 (52.1% (197/378) vs. 36.8% (32/87), χ2=6.654, P=0.010), while there was no significant difference in the proportion of MP in 2012-2015 and that in 2008-2011 (36.8% (32/87) vs. 31.0% (9/29), χ²=0.314, P=0.575).Regarding the regional distribution, 342 cases were in the southern China and 152 in the northern China. Also, MP was the most common pathogen in both regions, but the proportion of MP was higher and the proportion of SP was lower in the north than those in the south (60.5% (92/152) vs. 42.7% (146/342), χ2=13.409, P<0.010; 7.9% (12/152) vs. 14.3% (49/342), χ2=4.023, P=0.045). Comparing the clinical characteristics of different pathogens, we found that fever and cough were the common symptoms in both single MP and single bacterial groups, but chest pain was more common (17.0% (34/200) vs. 6.1% (6/98), χ2=6.697, P=0.010) while shortness of breath and wheezing were less common in MP group (16.0% (32/200) vs. 60.2% (59/98), χ2=60.688, P<0.01; 4.5% (9/200) vs. 21.4% (21/98), χ2=20.819, P<0.01, respectively). The white blood cell count, C-reactive protein and procalcitonin in the bacterial group were significantly higher than those in the MP group (14.7 (1.0-67.1)×109/L vs. 10.5 (2.5-32.2)×109/L, 122.5 (0.5-277.3) mg/L vs. 51.4 (0.5-200.0) g/L, 2.13 (0.05-100.00) μg/L vs. 0.24 (0.01-18.85) μg/L, Z=-3.719, -5.901 and -7.765, all P<0.01). Conclusions: The prevalence of pediatric NP in China shows an increasing trend during the past years. MP, SP and SA are the main pathogens of NP, and the most common clinical symptoms are fever and cough. The WBC count, C-reactive protein and procalcitonin in bacterial NP are significantly higher than those caused by MP.
Collapse
Affiliation(s)
- Y L Zhou
- Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - J R Liu
- Department No.2 of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - Q W Yi
- Department of Pulmonology, Shenzhen Children's Hospital, Shenzhen 518038, China
| | - L N Chen
- Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - Z Y Han
- Department of Pulmonology, Children's Hospital of Shanxi Province, Taiyuan 030013, China
| | - C D Xu
- Department of Pulmonology, Children's Hospital of Nanjing Medical University, Nanjing 210019, China
| | - S Y Liu
- Department of the Second Respiratory, Tianjin Children's Hospital, Tianjin 300074, China
| | - C L Hao
- Department of Pulmonology, Children's Hospital of Soochow University, Suzhou 215003, China
| | - J Liu
- Department of Pediatrics, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
| | - Q L Li
- Department of Pediatric Respiratory Disease, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325027, China
| | - L J Wang
- First Department of Respiratory Medicine, Xi'an Children's Hospital, Xi'an 710003, China
| | - C Wang
- Department of Respiratory, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200062, China
| | - G H Che
- Department of Pediatrics, Second Affiliated Hospital of Jilin University, Changchun 130000, China
| | - Y Y Zhang
- Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - L Tong
- Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - Y Q Liu
- Department No.2 of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - S Y Zhao
- Department No.2 of Respiratory Medicine, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China
| | - Y J Zheng
- Department of Pulmonology, Shenzhen Children's Hospital, Shenzhen 518038, China
| | - S Li
- Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - H M Liu
- Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China
| | - J Chang
- Department of Pulmonology, Children's Hospital of Shanxi Province, Taiyuan 030013, China
| | - D Y Zhao
- Department of Pulmonology, Children's Hospital of Nanjing Medical University, Nanjing 210019, China
| | - Y X Zou
- Department of the Second Respiratory, Tianjin Children's Hospital, Tianjin 300074, China
| | - X X Zhang
- Department of Pulmonology, Children's Hospital of Soochow University, Suzhou 215003, China
| | - G M Nong
- Department of Pediatrics, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
| | - H L Zhang
- Department of Pediatric Respiratory Disease, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325027, China
| | - J L Pan
- First Department of Respiratory Medicine, Xi'an Children's Hospital, Xi'an 710003, China
| | - Y N Chen
- First Department of Respiratory Medicine, Xi'an Children's Hospital, Xi'an 710003, China
| | - X Y Dong
- Department of Respiratory, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200062, China
| | - Y F Zhang
- Department of Pediatrics, Second Affiliated Hospital of Jilin University, Changchun 130000, China
| | - Y S Wang
- Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - D H Yang
- Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| | - Q Lu
- Department of Respiratory, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200062, China
| | - Z M Chen
- Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China
| |
Collapse
|
34
|
Xu M, Cai SJ, Wen SH, Zhang HL. [Imaging features and management strategies of pulmonary nodules in children]. Zhonghua Er Ke Za Zhi 2021; 59:708-711. [PMID: 34333928 DOI: 10.3760/cma.j.cn112140-20210304-00180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- M Xu
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - S J Cai
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - S H Wen
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - H L Zhang
- Department of Pediatric Respiratory Medicine, the Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| |
Collapse
|
35
|
Zhang XY, Yang YS, Shang QX, Gu YM, Shi GD, Zhang HL, Li XY, Chen LQ. [Correlation between preoperative inflammatory biomarkers and postoperative pneumonia or long-term prognosis in patients with esophageal cancer after neoadjuvant therapy]. Zhonghua Wai Ke Za Zhi 2021; 59:660-666. [PMID: 34192858 DOI: 10.3760/cma.j.cn112139-20210201-00060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Objective: To examine the correlation between neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR) and neutrophil-monocyte ratio (NMR) for postoperative pneumonia or long-term overall survival in patients with esophageal cancer after neoadjuvant therapy. Methods: The clinical data of 137 patients, including 111 males and 26 females, with the age of (M(QR))61(10) years (range: 45 to 75 years), undergoing radical resection of esophageal cancer after neoadjuvant therapy admitted at Department of Thoracic Surgery, West China Hospital from January 2016 to May 2019 were analyzed retrospectively. The blood routine one or two days before surgery and the occurrence of pneumonia after surgery were collected via hospital information system. The absolute count of neutrophils, lymphocytes and monocytes was recorded, to calculate NLR, LMR and NMR. The survival of patients was recorded systematically via follow-up. In the first part, the influencing factors of postoperative inflammation were analyzed, to group the patients into two groups according to the occurrence of postoperative pneumonia. χ2 test, t-test or rank-sum test were conducted for inter-group comparison. In the second part, cutoff values of inflammatory biomarkers were obtained with the receiver operating characteristic (ROC) curve and grouped, with postoperative pneumonia as endpoint criteria. Independent factors correlated with postoperative pneumonia were determined through univariate and multivariate Logistic regression analysis. In the third part, the analysis on prognosis factors was carried on, with the survival as endpoint criteria. Cutoff values of inflammatory biomarkers were obtained with X-Tile software and grouped. The survival analysis was carried on with univariate and multivariate Cox proportional hazards regression model, and the Kaplan-Meier curve was drawn finally. The results of survival analysis were verified by Log-rank test. Results: Median follow-up time was 614 (299) days (range: 382 to 1 612 days). Cutoff values of NLR, LMR, and NMR obtained via the ROC curve were 3.0, 3.9, and 6.2, respectively. According to the multivariate Logistic regression analysis, NLR>3.0 (OR=2.740, 95% CI: 1.221 to 6.152, P=0.015) and LMR>3.9 (OR=0.140, 95% CI: 0.022 to 0.890, P=0.037) were independent prognosis factors for postoperative pneumonia in patients with esophageal cancer after neoadjuvant therapy. Cutoff values of NLR, LMR, and NMR obtained with X-Tile software were 3.3, 4.2, and 7.2, respectively. Through multivariate Cox proportional risk regression analysis, late tumor ypTNM staging (8th AJCC) (HR=2.087, 95% CI:1.079 to 4.038, P=0.029), poor pathologic response (HR=2.251, 95% CI: 1.117 to 4.538, P=0.023), and LMR>4.2 (HR=0.347, 95% CI: 0.127 to 0.946, P=0.039) could be independent prognosis factors for overall survival. Kaplan-Meier survival analysis indicated that the overall survival of patients with LMR ≤4.2 was worse (P=0.002), with the 1-year overall survival rate of 82.9%, and the 1-year overall survival rate of patients with LMR>4.2 was 94.6%. Conclusion: Preoperative LMR ≤3.9 and NLR>3.0 can be considered as independent prognosis factors for postoperative pneumonia, while LMR≤4.2 as one of independent prognosis factors for overall survival.
Collapse
Affiliation(s)
- X Y Zhang
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Y S Yang
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Q X Shang
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Y M Gu
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - G D Shi
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - H L Zhang
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - X Y Li
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| | - L Q Chen
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
| |
Collapse
|
36
|
Niu Y, Li DM, Liu PP, Zhang HL, Zhong DR. [Eosinophilic solid and cystic renal cell carcinoma with tumor-induced osteomalacia: report of a case]. Zhonghua Bing Li Xue Za Zhi 2021; 50:829-831. [PMID: 34405628 DOI: 10.3760/cma.j.cn112151-20201225-00966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Y Niu
- Department of Pathology, the China-Japan Friendship Hospital, Beijing 100029, China
| | - D M Li
- Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - P P Liu
- Department of Pathology, the China-Japan Friendship Hospital, Beijing 100029, China
| | - H L Zhang
- Department of Pathology, the China-Japan Friendship Hospital, Beijing 100029, China
| | - D R Zhong
- Department of Pathology, the China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
37
|
Zheng X, He X, Yang Y, Liu X, Zhang LL, Qu BL, Zhong QZ, Qian LT, Hou XR, Qiao XY, Wang H, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Zhang HL, Su H, Song YQ, Zhu J, Zhang YJ, Huang HQ, Wang Y, Chen F, Yin L, Qi SN, Li YX. Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG study. ESMO Open 2021; 6:100206. [PMID: 34242966 PMCID: PMC8271122 DOI: 10.1016/j.esmoop.2021.100206] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2021] [Revised: 06/08/2021] [Accepted: 06/21/2021] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND This study evaluated the survival benefit of asparaginase (ASP)-based versus non-ASP-based chemotherapy combined with radiotherapy in a real-world cohort of patients with early-stage extranodal nasal-type natural killer/T-cell lymphoma (ENKTCL). PATIENTS AND METHODS We identified 376 patients who received combined radiotherapy with either ASP-based (ASP, platinum, and gemcitabine; n = 286) or non-ASP-based (platinum and gemcitabine; n = 90) regimens. The patients were stratified into low-, intermediate-, and high-risk groups using the early stage-adjusted nomogram-revised risk index. Overall survival (OS) and distant metastasis (DM)-free survival (DMFS) between the chemotherapy regimens were compared using inverse probability of treatment weighting (IPTW) and multivariable analyses. RESULTS ASP-based (versus non-ASP-based) regimens significantly improved 5-year OS (84.5% versus 73.2%, P = 0.021) and DMFS (84.4% versus 74.5%, P = 0.014) for intermediate- and high-risk patients, but not for low-risk patients in the setting of radiotherapy. Moreover, ASP-based regimens decreased DM, with a 5-year cumulative DM rate of 14.9% for ASP-based regimens compared with 25.1% (P = 0.014) for non-ASP-based regimens. The survival benefit of ASP-based chemotherapy and radiotherapy remained consistent after adjusting the confounding variables using IPTW and multivariate analyses; additional sensitivity analyses confirmed these results. CONCLUSIONS The findings provided support for ASP-based chemotherapy and radiotherapy as a first-line treatment strategy for intermediate- and high-risk early-stage ENKTCL.
Collapse
Affiliation(s)
- X Zheng
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - X He
- Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, PR China
| | - Y Yang
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - X Liu
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China
| | - L L Zhang
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, PR China
| | - B L Qu
- The General Hospital of Chinese People's Liberation Army, Beijing, PR China
| | - Q Z Zhong
- Beijing Hospital, National Geriatric Medical Center, Beijing, PR China
| | - L T Qian
- The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui, PR China
| | - X R Hou
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, PR China
| | - X Y Qiao
- The Fourth Hospital of Hebei Medical University, Shijiazhuang, PR China
| | - H Wang
- Second Affiliated Hospital of Nanchang University, Nanchang, PR China
| | - Y Zhu
- Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Cancer and Basic Medicine (IBMC), Chinese Academy of Sciences, Zhejiang, PR China
| | - J Z Cao
- Shanxi Cancer Hospital, the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, PR China
| | - J X Wu
- Fujian Provincial Cancer Hospital, Fuzhou, Fujian, PR China
| | - T Wu
- Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, Guizhou, PR China
| | - S Y Zhu
- Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hunan, PR China
| | - M Shi
- Xijing Hospital of Fourth Military Medical University, Xi'an, PR China
| | - L M Xu
- Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, PR China
| | - H L Zhang
- Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, PR China
| | - H Su
- The Fifth Medical Center of PLA General Hospital, Beijing, PR China
| | - Y Q Song
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, PR China
| | - J Zhu
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, PR China
| | - Y J Zhang
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China
| | - H Q Huang
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China
| | - Y Wang
- Chongqing University Cancer Hospital, Chongqing Cancer Hospital, Chongqing
| | - F Chen
- Affiliated Hospital of Qinghai University, Qinghai, PR China
| | - L Yin
- Affiliated Hospital of Qinghai University, Qinghai, PR China
| | - S N Qi
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
| | - Y X Li
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
| |
Collapse
|
38
|
Wang YJ, Zhang HL, Song H, Zhang F, Xi YF. [Research progress on prognostic factors of extranodal NK/T-cell lymphoma]. Zhonghua Bing Li Xue Za Zhi 2021; 50:691-694. [PMID: 34078068 DOI: 10.3760/cma.j.cn112151-20201224-00958] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Y J Wang
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030000, China
| | - H L Zhang
- Department of Pathology, Second Medical College of Shanxi Medical University, Taiyuan 030000, China
| | - H Song
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030000, China
| | - F Zhang
- School of Basic Medicine, Shanxi Medical University, Taiyuan 030000, China
| | - Y F Xi
- Department of Pathology, Shanxi Cancer Hospital, Taiyuan 030000, China
| |
Collapse
|
39
|
Zhao SM, Liu YM, Liu N, Zhang HL, Song ZF, Gao WH, Lan YH, Fan AW, Liu XL. [Clinical effects of retrograde anterolateral thigh perforator flaps assisted with computed tomography angiography in repairing skin and soft tissue defects around the knee or in proximal lower leg]. Zhonghua Shao Shang Za Zhi 2021; 37:356-362. [PMID: 33874708 DOI: 10.3760/cma.j.cn501120-20200905-00401] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the clinical effects of retrograde anterolateral thigh perforator flaps assisted with computed tomography angiography (CTA) in repairing skin and soft tissue defects around the knee or in proximal lower leg. Methods: A retrospective cohort study was conducted. From May 2015 to October 2019, 17 patients with skin and soft tissue defects around the knee or in proximal lower leg were admitted to the Department of Orthopedics of Jizhong Energy Xingtai Mig General Hospital, including 12 males and 5 females, aged 16-65 years, with an average age of 35 years. The areas of skin and soft tissue defects after debridement ranged from 6.0 cm×3.0 cm to 15.0 cm×9.0 cm. The retrograde anterolateral thigh perforator flaps were designed according to the origin and distribution of the perforating branches in flaps and the length of the vascular pedicle examined with CTA and the condition of the wound to repair the wounds. The areas of resected flaps ranged from 6.5 cm×3.5 cm to 15.5 cm×9.5 cm. The wounds in donor sites of flaps were sutured directly or covered with medium-thickness skin grafts from healthy upper leg. The sources of the perforating branches in flaps were recorded. The lateral circumflex femoral artery, its branches, and the relative length of the vascular pedicle were compared between preoperative CTA detection and intraoperative observation. The survivals of the flaps were observed. At the last follow-up, the effects of flaps in repairing wounds were evaluated according to evaluation standard of efficacy satisfaction; the motion ranges of flexion and extension of the knee joint were measured, and the knee joint function was evaluated according to the Hohl knee joint function evaluation standard; the sensory function in the flap area was evaluated according to the sensory function evaluation standard formulated by the British Medical Research Council; the wound healing and the occurrence of complication affecting motor function of limb of flap donor sites was observed. Data were statistically analyzed with paired sample t test. Results: The perforating branches in flaps originated from descending branches, oblique branches, and rectus femoris branches of lateral circumflex femoral artery in 7, 6, and 4 patients, respectively. The flaps with blood supply from descending branches, oblique branches, and rectus femoris branches of lateral circumflex femoral artery were type 1, 2, and 3 retrograde anterolateral thigh perforator flaps, respectively. The preoperative CTA examination of lateral circumflex femoral artery and its branches were consistent with those observed during operation. The relative lengths of vascular pedicles of type 1, 2, and 3 retrograde anterolateral thigh perforator flaps calculated after CTA examination were 0.32±0.13, 0.56±0.07, and 0.56±0.15, which were close to 0.35±0.12, 0.52±0.10, and 0.53±0.12 measured and calculated during operation, respectively (t=0.45, 0.80, 0.31, P>0.05). All flaps survived in 17 cases without vascular crisis. At the last follow-up, 16 patients were satisfied with effects of flaps in wound repair, with 1 patient feeling average about the effect; the flexion range of knee joint was 100-120°, and the extension range of knee joint was -2-0°; knee joint function was evaluated as excellent in 9 cases, good in 7 cases, and poor in 1 case; the sensory function of the flap area reached S4 level in 2 cases, S3 level in 8 cases, and S2 level in 7 cases; the wounds in flap donor sites healed well; there was no adverse effect in motor function of limbs. Conclusions: Retrograde anterolateral thigh perforator flap is an effective method for repairing skin and soft tissue defects around the knee or in proximal lower leg. Preoperative CTA examination can fully show the anatomical characteristics of the branches of the lateral circumflex femoral artery and the perforating vessels of each branch, which can guide preoperative flap design and operation, thus shortening operation time and improving flap survival rate, with good clinical effects.
Collapse
Affiliation(s)
- S M Zhao
- Department of Orthopedics, Jizhong Energy Xingtai Mig General Hospital, Xingtai 054000, China
| | - Y M Liu
- Department of Urology, Yidu Central Hospital of Weifang, Weifang 262500, China
| | - N Liu
- Medical Management Division, Jizhong Energy Xingtai Mig General Hospital, Xingtai 054000, China
| | - H L Zhang
- Department of Orthopedics, Jizhong Energy Xingtai Mig General Hospital, Xingtai 054000, China
| | - Z F Song
- Department of Orthopedics, Jizhong Energy Xingtai Mig General Hospital, Xingtai 054000, China
| | - W H Gao
- Department of Orthopedics, Jizhong Energy Xingtai Mig General Hospital, Xingtai 054000, China
| | - Y H Lan
- Department of Orthopedics, Jizhong Energy Xingtai Mig General Hospital, Xingtai 054000, China
| | - A W Fan
- Department of Orthopedics, Jizhong Energy Xingtai Mig General Hospital, Xingtai 054000, China
| | - X L Liu
- Department of Orthopedics, Jizhong Energy Xingtai Mig General Hospital, Xingtai 054000, China
| |
Collapse
|
40
|
Zhang HL, Feng ZC, Cheng Y, Zhao Z, Chen YF, Liu CJ, Cheng DL, Shi CS, Wang F, Wang J, Jin YP, Yin Y, Lu GP, Hong XY. [Risk factors for mortality in pediatric acute respiratory distress syndrome requiring extracorporeal membrane oxygenation support]. Zhonghua Er Ke Za Zhi 2021; 59:380-386. [PMID: 33902222 DOI: 10.3760/cma.j.cn112140-20210222-00148] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the risk factors for mortality in pediatric acute respiratory distress syndrome (PARDS) requiring extracorporeal membrane oxygenation (ECMO) support. Methods: Clinical data of 109 patients with severe PARDS supported by ECMO, who were hospitalized in 6 ECMO centers in China from September 2012 to February 2020, were retrospectively analyzed. They were divided into survival group and death group according to the prognosis. Chi-square test and rank sum test were used to compare the variables between the two groups, including the demographic data, laboratory examination results, clinical data before and after ECMO, and other supportive treatment. Univariate and multivariate Logistic regression models were used to analyze the prognostic risk factors. Results: In these 109 cases, 54 died and 55 survived. Compared with the survival group, the death group had higher incidences of acute kidney injury (AKI) (48.1% (26/54) vs. 21.8% (12/55), χ²=8.318, P=0.004) and coagulation dysfunction (22.2% (12/54) vs. 7.3% (4/55), χ²=4.862, P=0.027), and higher rate of renal replacement therapy (48.1% (26/54) vs. 21.8% (12/55), χ²=9.694, P=0.008) during ECMO support. Logistic regression analysis showed that continuous renal replacement therapy (CRRT) and AKI were independent risk factors for death in patients with severe PARDS requiring ECMO support (HR=3.88,95%CI 1.04-14.52, HR=4.84,95%CI 1.21-19.46, both P<0.05). Conclusion: AKI and CRRT are independent risk factors for predicting mortality in patients with severe PARDS requiring ECMO support.
Collapse
Affiliation(s)
- H L Zhang
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China
| | - Z C Feng
- Pediatric Intensive Care Unit, Department of Pediatrics, People's Liberation Army General Hospital, the Second School of Clinical Medicine, Southern Medical University, Beijing 100700, China
| | - Y Cheng
- Pediatric Intensive Care Unit, Children's Hospital of Fudan University, Shanghai 201102, China
| | - Z Zhao
- Pediatric Intensive Care Unit, Department of Pediatrics, People's Liberation Army General Hospital, the Second School of Clinical Medicine, Southern Medical University, Beijing 100700, China
| | - Y F Chen
- Pediatric Intensive Care Unit, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - C J Liu
- Pediatric Intensive Care Unit, Children's Hospital of Chongqing Medical University, Chongqing 400014, China
| | - D L Cheng
- Pediatric Intensive Care Unit, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - C S Shi
- Pediatric Intensive Care Unit, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - F Wang
- Pediatric Surgical Intensive Care Unit, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450053, China
| | - J Wang
- Pediatric Surgical Intensive Care Unit, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450053, China
| | - Y P Jin
- Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
| | - Y Yin
- Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
| | - G P Lu
- Pediatric Intensive Care Unit, Children's Hospital of Fudan University, Shanghai 201102, China
| | - X Y Hong
- Pediatric Intensive Care Unit, Department of Pediatrics, People's Liberation Army General Hospital, the Second School of Clinical Medicine, Southern Medical University, Beijing 100700, China
| |
Collapse
|
41
|
Cheng Y, He Y, Li W, Zhang HL, Zhou Q, Wang B, Liu C, Walding A, Saggese M, Huang X, Fan M, Wang J, Ramalingam SS. Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study. Target Oncol 2021; 16:165-176. [PMID: 33544337 PMCID: PMC7935816 DOI: 10.1007/s11523-021-00794-6] [Citation(s) in RCA: 59] [Impact Index Per Article: 19.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/27/2021] [Indexed: 12/11/2022]
Abstract
Background In the global FLAURA study, first-line osimertinib, a third-generation irreversible tyrosine kinase inhibitor (TKI) of epidermal growth factor receptor (EGFR), significantly improved progression-free survival (PFS) and overall survival (OS) versus comparator EGFR TKIs in patients with EGFR mutation-positive (EGFRm) advanced non-small-cell lung cancer (NSCLC). Objective The FLAURA China study assessed first-line osimertinib in Chinese patients with EGFRm advanced NSCLC (NCT02296125). Methods FLAURA China was a double-blind, randomized, phase III study. Adults from mainland China with previously untreated EGFRm (Exon 19 deletion or L858R) advanced NSCLC were enrolled in the global study or a China-only study under the same protocol; 136 patients were randomized to osimertinib (80 mg once daily [od]; n = 71) or comparator EGFR TKI (gefitinib or erlotinib; all sites selected gefitinib 250 mg od; n = 65). Patients were randomized and allocated to treatment groups by a central computer system. Treatment continued until disease progression, unacceptable toxicity, or withdrawal of consent. The primary endpoint was investigator-assessed PFS; OS was a secondary endpoint. Results All 136 randomized patients were analyzed. Osimertinib extended median PFS by 8.0 months versus comparator EGFR TKI (17.8 vs. 9.8 months; hazard ratio [HR] 0.56; 95% confidence interval [CI] 0.37–0.85). Median OS was 33.1 months in the osimertinib group versus 25.7 months in the comparator group (HR 0.85; 95% CI 0.56–1.29). At 3 years, 20% of patients on osimertinib and 8% on the comparator remained on randomized treatment. Grade 3 or higher adverse events (AEs) were reported in 54 and 28% of patients in the osimertinib and comparator groups, respectively, driven by increased local reporting of laboratory- and disease-related AEs. No new safety signals were identified. Conclusions First-line osimertinib treatment resulted in a clinically meaningful PFS and OS benefit versus comparator EGFR TKI in Chinese patients with EGFRm advanced NSCLC. Safety data were consistent with the known safety profile of osimertinib. Clinical Trial Registration ClinicalTrials.gov NCT02296125, registered 20 November 2014 Supplementary Information The online version contains supplementary material available at 10.1007/s11523-021-00794-6.
Collapse
Affiliation(s)
- Ying Cheng
- Department of Medical Oncology, Jilin Provincial Cancer Hospital, Changchun, 130000, China.
| | - Yong He
- Respiratory Disease, Daping Hospital, Chongqing, China
| | - Wei Li
- The First Hospital of Jilin University, Changchun, Jilin, China
| | - He-Long Zhang
- Tangdu Hospital of Fourth Military Medical University, Xi'an, Shaanxi, China
| | - Qing Zhou
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China
| | - Buhai Wang
- Department of Oncology of Subei People's Hospital, Yangzhou University, Yangzhou, Jiangsu, China
| | - Chunling Liu
- Tumor Hospital, Xinjiang Medical University, Urumqi, China
| | - Andrew Walding
- Global Medicines Development, GMED Oncology, AstraZeneca, Cambridge, UK
| | - Matilde Saggese
- Global Medicines Development, GMED Oncology, AstraZeneca, Cambridge, UK
| | - Xiangning Huang
- Global Medicines Development, GMED Oncology, AstraZeneca, Cambridge, UK
| | - Minhao Fan
- Global Medicines Development, AstraZeneca, Shanghai, China
| | - Jia Wang
- Global Medicines Development, AstraZeneca, Shanghai, China
| | - Suresh S Ramalingam
- Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA
| |
Collapse
|
42
|
Xie JS, Yin XJ, Yan YN, Pei QY, Yan LH, Zhang L, Liu J, Liu G, Zhang HL, Zhang XH. [Integrated management and prognosis analysis of fetus with complete transposition of the great arteries during pregnancy and perinatal period]. Zhonghua Fu Chan Ke Za Zhi 2021; 55:830-836. [PMID: 33355757 DOI: 10.3760/cma.j.cn112141-20200516-00417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the prenatal diagnosis, integrated management and prognosis of fetal complete transposition of the great arteries (D-TGA) detected by ultrasonography. Methods: The prenatal diagnosis, integrated management and prognosis of 19 D-TGA fetuses found by ultrasound during pregnancy in Peking University People's Hospital from January 2014 to June 2019 were analyzed retrospectively. Results: The incidence of D-TGA was 0.12% (19/16 028) among fetuses diagnosed by ultrasound during 5 years. Among the 19 cases, there were 7 cases (7/19) of D-TGA alone, 7 cases (7/19) of D-TGA combined with ventricular septal defect (VSD), 5 cases (5/19) of D-TGA combined with other cardiac malformations; 2 cases (2/19) of D-TGA combined with extra cardiac malformations, and 1 case (1/19) of fetal growth restriction. Nuchal translucency (NT) thickening was found in 3 cases (3/19) at the first trimester of pregnancy. Among the 19 D-TGA fetuses found by ultrasound examination, 18 (18/19) had chromosome karyotype analysis of fetuses or newborns, and chromosomal abnormalities were found in 2 cases, all of which were terminated in the second trimester of pregnancy. The integrated management and multidisciplinary diagnosis and treatment of D-TGA fetuses during pregnancy and perinatal period were carried out. Nine cases (9/19) had induction in the second trimester of pregnancy, 10 cases (10/19) were delivered at term, and the gestational week of delivery was (38.3±0.7) weeks, among which 6 cases (6/10) were delivered by caesarean section due to obstetric factors, and 4 cases (4/10) were delivered by vaginal birth. The oxygen saturation was (69.2±11.3)% at birth and (77.8±6.7)% when transferred to the department of pediatrics. Except for one case lost to follow-up, the other 9 newborns received operation. The average operation time was (21.8±22.1) days after birth, 8 cases (8/9) completed one operation and 1 case (1/9) performed two operations. All of the 9 cases treated by surgery were followed up well. Conclusions: Prenatal diagnosis, individualized evaluation and integrated management during pregnancy and perinatal period should be carried out for the patients with fetal D-TGA detected by ultrasound. Fetal D-TGA is not an indication of cesarean section. The open of ductus arteriosus can be maintained with drugs when necessary after birth, and a good prognosis could be obtained through surgery.
Collapse
Affiliation(s)
- J S Xie
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China
| | - X J Yin
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China
| | - Y N Yan
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China
| | - Q Y Pei
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China
| | - L H Yan
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China
| | - L Zhang
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China
| | - J Liu
- Department of Pediatrics, Peking University People's Hospital, Beijing 100044, China
| | - G Liu
- Department of Cardiac Surgery, Peking University People's Hospital, Beijing 100044, China
| | - H L Zhang
- Department of Pediatric Cardiac Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
| | - X H Zhang
- Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China
| |
Collapse
|
43
|
Wang B, Zhang T, Liu HY, Chen RR, Zhang XY, Zhang HL, Zhai ZG, Zhong DR. [Clinicopathological characteristics of pulmonary artery intimal sarcoma]. Zhonghua Bing Li Xue Za Zhi 2021; 50:38-43. [PMID: 33396985 DOI: 10.3760/cma.j.cn112151-20200413-00313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To describe the clinicopathological features of pulmonary artery intimal sarcoma (PAIS), and to understand its molecular alterations. Methods: Sixty cases of pulmonary artery endarterectomy performed at the China-Japan Friendship Hospital, Beijing, China from January 2017 to January 2020 were reviewed. Clinical data of 5 patients with pulmonary artery intimal sarcoma were collected. Hematoxylin-eosin staining, immunohistochemistry staining and fluorescence in situ hybridization (FISH) were performed to evaluate the pathological features. RNA sequencing was conducted to assess the fusion gene changes in PAIS. Results: The detection rate of PAIS was 8.3% (5/60), with the median age of 49 years and a female predominance. Their clinical manifestations were non-specific. Histopathological examination showed that the tumors were composed of malignant spindle or epithelioid cells, with various degrees of atypia. Focal heterologous osteosarcomatous or leiomyosarcomatous differentiation was noted. The tumor cells could express PDGFRA, CDK4 and MDM2 with co-amplification of MDM2, CDK4 and EGFR genes. RNA sequencing detected multiple in-frame fusions in the tumors. Conclusions: PAIS is a rare, highly heterogeneous, and poorly-or un-differentiated sarcoma accompanied by complex changes of multiple genes.It has no known effective treatments, and thus has a poor prognosis.
Collapse
Affiliation(s)
- B Wang
- Department of Pathology, China-Japan Friendship Hospital, Beijing 100029, China
| | - T Zhang
- Department of Pathology, China-Japan Friendship Hospital, Beijing 100029, China
| | - H Y Liu
- Department of Pathology, China-Japan Friendship Hospital, Beijing 100029, China
| | - R R Chen
- Geneplus-Beijing Ltd., Beijing 102206, China
| | - X Y Zhang
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - H L Zhang
- Department of Pathology, China-Japan Friendship Hospital, Beijing 100029, China
| | - Z G Zhai
- Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - D R Zhong
- Department of Pathology, China-Japan Friendship Hospital, Beijing 100029, China
| |
Collapse
|
44
|
Chen GS, Zhang HL, Liu RZ, Gu GZ, Yu SF. [Analysis on the effect of sound insulation reconstruction in operation room of steel rolling production line in a steel plant]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2020; 38:582-585. [PMID: 32892584 DOI: 10.3760/cma.j.cn121094-2191028-00506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the effect of sound insulation improvement on the noise exposure of workers in the operation room of hot rolling line for wide and heavy plate. Methods: From September 2019 to September 2017, based on the occupational health Survey, the data of 25 fixed operation rooms and workers in operation rooms of a steel rolling production line were collected retrospectively, the noise exposure levels before and after the improvement of sound insulation were statistically analyzed. Results: The noise exposure value of the workers, the qualified rate of 0 Grade 8 hours equivalent noise (L(EX, 8 h)) ≤85 dB (A) and the qualified rate of the design limit value of the operation room were all higher than those before the modification, the difference was statistically significant (P<0.01) , after the renovation, the Class II and above noise hazards were eliminated, the equivalent continuous a sound level (L(Aeq, 8 h)) >75 dB (A) of the workers in the operation room was 8h, and the noise level in the operation room still did not meet the Ergonomics limit standard. Conclusion: The improvement of sound insulation can effectively improve the working environment of noise workplace operating room and reduce the workers'noise exposure level.
Collapse
Affiliation(s)
- G S Chen
- Wugang Institute for Occupational Health, Wugang 462500, China
| | - H L Zhang
- Wugang Institute for Occupational Health, Wugang 462500, China
| | - R Z Liu
- General Hospital of Wugang Company, Wugang 462500, China
| | - G Z Gu
- Henan Provincial Institute for Occupational Health, Zhengzhou 450052, China
| | - S F Yu
- Henan Medical College, Zhengzhou 451191, China
| |
Collapse
|
45
|
Zhang HL, Bai ZY, Zhang MX, Xi YF. [Advances in molecular genetics of acute T lymphoblastic lymphoma/leukemia]. Zhonghua Bing Li Xue Za Zhi 2020; 49:870-873. [PMID: 32746564 DOI: 10.3760/cma.j.cn112151-20191201-00770] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- H L Zhang
- Department of Pathology, Second Medical College of Shanxi Medical University, Taiyuan 030000, China
| | - Z Y Bai
- Shanxi Medical University, Taiyuan 030000, China
| | - M X Zhang
- Department of Rheumatology and Immunology, Second Medical College of Shanxi Medical University, Taiyuan 030000, China
| | - Y F Xi
- Departmentof Pathology, Shanxi Cancer Hospital, Taiyuan 030000, China
| |
Collapse
|
46
|
Wang F, Liu TS, Yuan XL, Luo HY, Gu KS, Yuan Y, Deng YH, Xu JM, Bai YX, Wang Y, Liao WJ, Zhang HL, Bi F, Wang BM, Zhuang ZX, Jiang TJ, Xu RH. Trastuzumab plus docetaxel and capecitabine as a first-line treatment for HER2-positive advanced gastric or gastroesophageal junction cancer: a phase II, multicenter, open-label, single-arm study. Am J Cancer Res 2020; 10:3037-3046. [PMID: 33042632 PMCID: PMC7539783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2020] [Accepted: 05/14/2020] [Indexed: 06/11/2023] Open
Abstract
Gastric cancer (GC) is the second most common cancer in China. The ToGA study showed that trastuzumab in combination with fluoropyrimidine plus cisplatin prolonged overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)-positive advanced GC (AGC). However, some patients may not be able to receive this regimen. We conducted a clinical study to evaluate the efficacy and safety of trastuzumab in combination with docetaxel+capecitabine (DX) in patients with HER2-positive AGC. This phase II, multi-center, open-label, single arm study enrolled patients with HER2-positive AGC who had not received prior treatment for metastatic disease. Patients were treated with a regimen of trastuzumab (8 mg/kg loading dose followed by 6 mg/kg, day 1), capecitabine (1000 mg/m2 twice daily, days 1-14) and docetaxel (60 mg/m2, day 1 for 6 cycles) every 3 weeks. The primary endpoint was progression-free survival (PFS) and the secondary endpoints were objective response rate (ORR), OS and safety profiles. Sixty-seven patients with AGC were enrolled from 14 centers. 64 were included in the full analysis set (FAS). The median PFS was 8.1 months (95% confidence interval [CI]: 5.6-12.8) and the median OS was 20.9 months (95% CI: 15.1-33.0). Response was evaluated in 59 patients. The ORR was 67.8%. The most common adverse events of Grade ≥3 were neutropenia, leukopenia, hand-foot syndrome, febrile neutropenia and anemia. We concluded that combination treatment with trastuzumab and DX was well-tolerated and highly effective in patients with HER2-positive AGC, and may offer an alternative to current treatments.
Collapse
Affiliation(s)
- Feng Wang
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineGuangzhou, China
| | - Tian-Shu Liu
- Zhongshan Hospital, Fudan UniversityShanghai, China
| | - Xiang-Lin Yuan
- Tongji Hospital, Huazhong University of Science and TechnologyWuhan, China
| | - Hui-Yan Luo
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineGuangzhou, China
| | - Kang-Sheng Gu
- The First Affiliated Hospital of Medical University of AnhuiHefei, China
| | - Ying Yuan
- The Second Affiliated Hospital of Medical College of Zhejiang UniversityHangzhou, China
| | - Yan-Hong Deng
- The 6th Affiliated Hospital, Sun Yat-sen UniversityGuangzhou, China
| | | | | | - Ying Wang
- Shengjing Hospital, China Medical UniversityShenyang, China
| | - Wang-Jun Liao
- Nanfang Hospital, Southern Medical UniversityGuangzhou, China
| | - He-Long Zhang
- Tangdu Hospital, Fourth Military Medical UniversityXian, China
| | - Feng Bi
- West China HospitalChengdu, China
| | - Bang-Mao Wang
- Tianjin Medical University General HospitalTianjin, China
| | - Zhi-Xiang Zhuang
- The Second Hospital Affiliated to Suzhou UniversitySuzhou, China
| | - Teng-Jia Jiang
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineGuangzhou, China
| | - Rui-Hua Xu
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineGuangzhou, China
| |
Collapse
|
47
|
Li HY, Chen B, Sun WM, Hu XG, Dong L, Zhang HL, Zheng YM. [Two cases of innominate artery compression syndrome in children]. Zhonghua Er Ke Za Zhi 2020; 58:679-681. [PMID: 32842390 DOI: 10.3760/cma.j.cn112140-20200110-00025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- H Y Li
- Department of Pediatric Pulmonology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - B Chen
- Department of Radiology, the Second Affliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - W M Sun
- Department of Pediatric Pulmonology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - X G Hu
- Department of Pediatric Pulmonology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - L Dong
- Department of Pediatric Pulmonology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - H L Zhang
- Department of Pediatric Pulmonology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| | - Y M Zheng
- Department of Pediatric Pulmonology, the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325027, China
| |
Collapse
|
48
|
Wang S, Zhang J, Zhang J, Zhang HL, Zhu GL, Yang YY, Wu SL. [A cohort study on the correlation between body mass index trajectories and new-onset non-alcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi 2020; 28:597-602. [PMID: 32791796 DOI: 10.3760/cma.j.cn501113-20190629-00230] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the correlation between the body mass index (BMI) trajectories and new-onset non-alcoholic fatty liver disease (NAFLD) so as to provide a scientific basis for the prevention and treatment of NAFLD. Methods: A total of 16388 observation subjects that met the inclusion criteria in the Kailuan study were used to form a cohort study. According to the BMI values of the observed subjects during annual physical examinations from 2006 to 2007, 2008 to 2009 and 2010 to 2011, SAS Proc Traj was used to determine four different BMI trajectories groups, namely, the low-stable medium-stable, medium-high and high-stable group. NAFLD incidence in each group was followed up during annual physical examinations from 2012 to 2013, 2014-2015 and 2016-2017. A total of 14998 observation subjects were finally included in the statistical analysis. The cumulative incidences of NAFLD differences in the four groups were compared. The Cox's proportional hazards regression model was used to analyze the correlation between different BMI trajectories and new-onset NAFLD. One-way analysis of variance was used to compare the intergroup difference of measurement data, and pairwise comparisons were conducted. LSD test was used for the homogeneity of variance. Dunnett's T3 test was used for heterogeneity of variances. χ (2) test was used to compare the count data, and the difference of NAFLD cumulative incidence rate between the different BMI trajectories groups was compared by log-rank test. Results: (1) the cumulative incidence of NAFLD was increased with the increase of BMI trajectories, which were 31%, 47%, 63%, 77%, respectively, and the difference was statistically significant (P < 0.01). (2) after adjusting for multiple confounding factors such as age and gender with the Cox's proportional hazards regression model, the risk of NAFLD in the BMI medium stable, medium-high, and high stable group was still 1.757 times [95% confidence interval (CI): 1.589 ~ 1.942], 2.612 (95%CI: 2.353 ~ 2.900), 3.566 (95%CI: 3.129 ~ 4.064) of the low-stable group (P < 0.01). Conclusion: The risk of NAFLD increases with increase of BMI trajectories, and long-term high levels of BMI are independent risk factors for the onset of NAFLD.
Collapse
Affiliation(s)
- S Wang
- Kailuan General Hospital in Tangshan, Hebei Province, Tangshan 063000, China
| | - J Zhang
- Kailuan General Hospital in Tangshan, Hebei Province, Tangshan 063000, China
| | - J Zhang
- Kailuan General Hospital in Tangshan, Hebei Province, Tangshan 063000, China
| | - H L Zhang
- Kailuan General Hospital in Tangshan, Hebei Province, Tangshan 063000, China
| | - G L Zhu
- Kailuan General Hospital in Tangshan, Hebei Province, Tangshan 063000, China
| | - Y Y Yang
- Kailuan General Hospital in Tangshan, Hebei Province, Tangshan 063000, China
| | - S L Wu
- Kailuan General Hospital in Tangshan, Hebei Province, Tangshan 063000, China
| |
Collapse
|
49
|
Xie X, Zhang HL, Wu WY, Feng Y. [Preliminary clinical observations of retina injury in alkaline ocular trauma patients]. Zhonghua Yan Ke Za Zhi 2020; 56:514-518. [PMID: 32842333 DOI: 10.3760/cma.j.cn112142-20200301-00132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the features of the full-field electroretinogram (FERG) in patients with ocular surface alkaline injury, and to clarify the clinical significance of FERG examination in alkaline ocular trauma. Methods: Retrospective series of case study. A total of 22 patients with chemical ocular surface injury who were treated in the Department of Ophthalmology of Peking University Third Hospital from May 2018 to January 2020 were selected, including 20 males (25 eyes) and 2 females (2 eyes). The age ranged from 19 to 60 years old (average, 41). There were 17 eyes with alkaline ocular trauma, 7 eyes with thermal burn, and 3 eyes with acid ocular trauma. Seventeen contralateral healthy eyes in patients with unilateral mechanical trauma were used as controls. Fourteen alkaline trauma eyes with visual acuity records were further observed according to the degree of visual impairment. All patients were subjected to different flash intensity stimuli in accordance with a standard of the International Society for Clinical Electrophysiology of Vision for dark-adapted and light-adapted full-field FERG. One-way ANOVA and SNK-q was used for the comparison between groups. The unpaired t test was used for the comparison of patients with different vision. Results: Compared with healthy eyes the injured eyes' amplitude of dark adaption FERG b-wave under the dark stimulation of 0.01 cd·s·m-2 in alkaline ocular trauma, thermal burn, acid ocular trauma was (135±85), (169±55), and (112±43) versus (341±53) μV, respectively; compared with healthy eyes, the differences were statistically significant (F=31.38; q=8.94, 5.70, 5.45;all P<0.01). Compared with healthy eyes the injured eyes' amplitude of dark adaption FERG a-wave under the dark stimulation of 3.00 cd·s·m-2 in alkaline ocular trauma, thermal burn, acid ocular trauma was (178±78), (172±35), and (99±53) versus (334±60) μV, respectively; compared with healthy eyes, the differences were statistically significant (F=24.33; q=7.04, 5.60, 5.80;all P<0.01). Compared with healthy eyes the injured eyes' amplitude of dark adaption FERG b-wave under the dark stimulation of 3.00 cd·s·m-2 in alkaline ocular trauma, thermal burn, acid ocular trauma was (354±79), (342±77), and (352±201) versus (600±78) μV, respectively; compared with healthy eyes, the differences were statistically significant (F=27.68; q=8.11, 6.51, 4.48; all P<0.01). Compared with healthy eyes the injured eyes' amplitude of dark adaption FERG OPs under the dark stimulation of 3.00 cd·s·m-2 in alkaline ocular trauma, thermal burn, acid ocular trauma was (97±54), (107±41), and (45±22) versus (206±32) μV, respectively; compared with healthy eyes, the differences were statistically significant (F=25.03; q=7.36, 5.13, 5.96; all P<0.01).There was no significant difference in FERG between patients with visual acuity≥0.2 and those with visual acuity<0.2 (P>0.05) after alkaline ocular trauma. Conclusions: By detecting the amplitude change of FERG wave form of chemical ocular trauma, in this study, the amplitude of FERG wave form in alkaline ocular trauma was generally decreased. It's suggested that alkaline ocular trauma can cause damage to the rod and cone systems of retinal. (Chin J Ophthalmol, 2020, 56: 514-518).
Collapse
Affiliation(s)
- X Xie
- Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China
| | - H L Zhang
- Department of Biology, Drexel University, Philadelphia, USA
| | - W Y Wu
- Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China
| | - Y Feng
- Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China
| |
Collapse
|
50
|
Zhou WH, Gu GZ, Wu H, Li YH, Chen GS, Zhang HL, Yu SF, Zheng YX. [Prediction of KCNQ4gene polymorphism varies with CNE or noise exposure duration on the Risk of NIHL-Cox model analysis based on cohort study]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2020; 38:111-116. [PMID: 32306673 DOI: 10.3760/cma.j.issn.1001-9391.2020.02.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: The purpose of this study was to explore the association between gene in the potassium recycling pathway 4 (KCNQ4) polymorphisms and the susceptibility to noise-induced hearing loss (NIHL) , and analysis the effect of cumulative noise exposure (CNE) and noise exposure duration on this association. Methods: A nested case-control study with 1∶1 matched was used based on the cohort of noise exposure in a steel factory. A total of 286 cases were selected as the group of hearing loss and 286 controls were chosen according to the matching standards of same gender, same type of work, age difference ≤ 5 years, noise exposure duration ≤ 2 years. The single nucleotide polymorphisms (SNPs) of rs4660468, rs4660470, rs34287852 in KCNQ4 were genotyped by SNPscan(TM) method. The codominant, dominant and recessive models were established to study KCNQ4 polymorphisms and the susceptibility to NIHL by single-factor conditional logistic regression analysis. The COX regression analysis was used to analyze the risk of developing NIHL in individuals with different genotypes along with the extending of noise exposure duration or CNE. Results: In the case of CNE≤96 dB (A) ·year, the risk of developing NIHL in individuals with TA genotype of rs4660470 was 2.197 times than individuals with TT genotypes (95%CI: 1.032~4.677) , and those with TA+AA and TT genotypes (HR=2.467, 95%CI: 1.025~5.934) With the increase of noise exposure duration, in rs4660470, individuals with TA genotype had a higher risk of suffering NIHL than those with TT genotype (HR=1.461, 95%CI: 1.061~2.011) , individuals with TA and/or AA genotype had a earlier risk of suffering NIHL than those with TT genotype. Conclusion: The mutant allele A of rs4660470 in KCNQ4 may be a risk factor for developing NIHL, CNE≤100 dB (A) ·year or the increase of noise exposure duration may further increase the risk of NIHL.
Collapse
Affiliation(s)
- W H Zhou
- Henan Provincial Institute for Occupational Health, Zhengzhou 450052, China
| | - G Z Gu
- Henan Provincial Institute for Occupational Health, Zhengzhou 450052, China
| | - H Wu
- Henan Provincial Institute for Occupational Health, Zhengzhou 450052, China
| | - Y H Li
- Henan Provincial Institute for Occupational Health, Zhengzhou 450052, China
| | - G S Chen
- Wugang Institute for Occupational Health, Wugang 462599, China
| | - H L Zhang
- Wugang Institute for Occupational Health, Wugang 462599, China
| | - S F Yu
- Henan medical college, Zhengzhou 451191, China
| | - Y X Zheng
- College of Public Health, Qingdao University, Qingdao 266021, China
| |
Collapse
|